Page last updated: 2024-08-22

platinum and carboplatin

platinum has been researched along with carboplatin in 320 studies

Research

Studies (320)

TimeframeStudies, this research(%)All Research%
pre-199026 (8.13)18.7374
1990's84 (26.25)18.2507
2000's38 (11.88)29.6817
2010's90 (28.13)24.3611
2020's82 (25.63)2.80

Authors

AuthorsStudies
Guthrie, D; Parmar, M; Stewart, L; Williams, CJ1
Fox, BW; Jackson, H; McAuliffe, CA; Perera, A; Sharma, HL1
Kumazawa, J; Mihara, Y; Ueda, T; Uozumi, J; Yasumasu, T1
Klys, HS; Matheson, LM; McKay, K; Smyth, JF; Tothill, P1
Allegra, C; Jacob, J; Ozols, RF; Reed, E; Young, RC1
Harrap, KR; Nicolson, MC; O'Neill, CF; Orr, RM1
Hoskins, W; Markman, M1
Zhang, M1
den Engelse, L; Los, G; McVie, JG; Pinedo, HM; Smals, OA; van der Vlist, M; van Vugt, MJ1
van der Vijgh, WJ1
Dykes, PJ; Featherstone, J; Marks, R1
Brann, TW; Frei, E; Herman, TS; Holden, SA; Khandekar, V; Korbut, TT; Rosbe, KW; Sotomayor, EA; Teicher, BA1
Eguchi, K; Ohe, Y; Ohmori, T; Saijo, N; Sasaki, Y; Shinkai, T; Tamura, T1
de Graeff, A; Los, G; McVie, JG; Meesters, EW; Noteborn, HP; Ruevekamp, M; ten Bokkel Huinink, D; Verdegaal, E1
Arimoto, T; Fujii, T; Fujita, Y; Gotoh, T; Hiramori, N; Iwasaki, Y; Kida, T; Nakagawa, M; Nakamura, T; Sakai, M1
Crowther, D; Lind, MJ; McAuliffe, CA; Murphy, DJ; Sharma, H; Smith, A; Tinker, N1
Baumann, K; Duwe, J; Hannemann, J1
Ueda, T; Uozumi, J; Yasumasu, T1
de Vries, EG; Meijer, S; Mulder, NH; Postmus, PE; Sleijfer, DT; Smit, EF; Terheggen, PM; Uges, DR; Willemse, PH1
Christian, MC; den Engelse, L; Gill, I; Grunberg, S; Kortes, V; Michael, C; Muggia, FM; Parker, RJ; Reed, E; Terheggen, PM1
Gill, I; Grunberg, S; Muggia, FM; Parker, RJ; Reed, E; Tarone, R; Vionnet, JA1
de Leij, L; de Vries, EG; Hospers, GA; Meijer, C; Mulder, NH; Uges, DR1
Baumann, K; Hannemann, J1
Ostchega, Y; Ozols, RF; Poirier, MC; Reed, E; Steinberg, SM; Young, RC; Yuspa, SH1
Ewen, C; Hendry, JH1
De Spiegeleer, B; Jackson, H; McAuliffe, C; Reman, JP; Sharma, H; Tinker, N1
Binks, SP; Dobrota, M1
Azouri, H; Bidart, JM; Bohuon, C1
Abrams, MJ; Chan, V; Collins, LS; Herman, TS; Teicher, BA1
Antman, K; Begg, C; Eder, JP; Elias, A; Flaherty, M; Frei, E; Henner, WD; Schnipper, L; Shea, TC1
Fujita, H; Okamoto, M; Takao, A1
Majima, H1
Amer, M; el-Yazigi, A; Martin, CR1
Ewen, C; Fox, BW; Hendry, JH; McAuliffe, CA; Perera, A; Sharma, H1
Canetta, RM; Colombo, N; Deeb, G; Farmen, RH; Gaver, RC; George, AM; Green, MD; Morris, AD; Muggia, FM; Speyer, JL1
Dubbelman, R; Elferink, F; Klein, I; McVie, JG; ten Bokkel Huinink, WW; van der Vijgh, WJ1
Douple, EB; Spencer, F; Totten, MD1
Ishikawa, K; Kimura, K; Mase, H; Oguri, S; Sakakibara, T; Shimizu, T; Smyth, RD1
Fujiwara, K; Hayase, R; Kobashi, Y; Kohno, I; Miyagi, Y; Sekiba, K; Yoshinouchi, M1
Dible, SE; Harrap, KR; Siddik, ZH1
Adenis, L; Caty, A; Fournier, C; Hecquet, B; Lefebvre, JL1
Boxall, FE; Calvert, AH; Gore, ME; Gumbrell, LA; Newell, DR; Siddik, ZH; Smith, IE1
Elferink, F; Gall, HE; Klein, I; Pinedo, HM; van der Vijgh, WJ; Vermorken, JB1
Friedlos, F; Knox, RJ; Lydall, DA; Roberts, JJ1
Adenis, L; Hecquet, B; Lefebvre, JL; Leroy, A; Peyrat, JP1
Cucchi, CA; Frei, E; Henner, WD; Holden, SA; Kelley, MJ; Rosowsky, A; Shea, TC; Teicher, BA1
Baer, J; Harrison, R; McAuliffe, CA; Sharma, HL; Smith, AG; Zaki, A1
Coughlin, CT; Douple, EB; O'Hara, JA; Richmond, RC1
Dubbelman, R; Franklin, H; Klein, I; McVie, JG; ten Bokkel Huinink, W; van der Vijgh, W1
Kidani, Y1
Calvert, AH; Chadwick, R; Harland, SJ; Harrap, KR; Newell, DR; Siddik, ZH1
Aisner, J; Egorin, MJ; Olman, EA; Van Echo, DA; Whitacre, MY1
Balázová, E; Hrubisko, M; Ujházy, V1
Akaboshi, M; Kawai, K; Miyahara, T; Takada, S; Ujeno, Y1
Bosl, GJ; Motzer, RJ; Parker, RJ; Perera, F; Poirier, MC; Reed, E; Shamkhani, H; Tang, D; Tsai, WY1
Ishihara, H; Itamochi, H; Kanamori, Y; Kigawa, J; Minagawa, Y; Terakawa, N1
Li, M; Liu, J1
Douple, EB; O'Hara, JA; Wang, HJ; Yang, LX1
Chen, JT; Hasumi, K1
Blommaert, FA; Saris, CP1
Leibbrandt, ME; Wolfgang, GH1
de Vries, EG; Esselink, MT; Guchelaar, HJ; Meijer, C; Mulder, NH; Uges, DR; Vellenga, E1
Amorusi, P; Bansal, SK; Lessard, D; Selinger, K; Tonelli, AP; Yacobi, A1
Kikkawa, F; Kojima, M; Maeda, O; Oguchi, H; Suganuma, N; Tamakoshi, K; Tomoda, Y1
Adams, M; Fish, RG; Griffiths, H; James, K; Mason, M; Shelley, MD1
de Boer-Dennert, M; Ma, J; Planting, AS; Schellens, JH; Stoter, G; van der Burg, ME; van Ingen, HE; Verweij, J1
Boughattas, NA; Bouzouita, K; Bruguerolle, B; Fournier, C; Hecquet, B; Lévi, F; Omrane, B; Trabelsi, H1
Chang, MJ; Egorin, MJ; Erkmen, K; Furmanski, P; Johnson, CS; Modzelewski, RA; Reyno, LM; Vlock, DR; Yu, WD1
Frenkel, EP; Henner, WD; Mickey, BE; Neuwelt, EA; Wiliams, PC1
Cooper, KG; Kitchener, HC; Parkin, DE1
Asanami, S; Susami, E; Uchiyama, K1
Murakami, T; Nagai, N; Ohama, K1
Akiyama, K; Hongo, A; Kudo, T; Seki, S1
al-Sadhan, FA; Ali, PA; Dutton, J; el-Sharkawi, AM; Evans, CJ; Hancock, DA; Lewis, DG1
Cho, T; Ikarashi, H; Kaneko, T; Kodama, S; Kurata, H; Suzuki, E; Suzuki, K; Tanaka, K; Yoshiya, N; Yoshizawa, H1
den Engelse, L; Los, G; Pinedo, HM; van Vugt, MJ1
Benatti, U; De Flora, A; Gasparini, A; Giovine, M; Tonetti, M1
Blommaert, FA; den Engelse, L; Hart, AA; Kortes, V; Michael, C; Muggia, FM; Schornagel, JH; Terheggen, PM1
Baskett, G; Chu, G; Mantin, R; Shen, YM; Sussman, H1
Los, G; Muggia, FM1
Baba, H; Kusumoto, H; Kusumoto, T; Maehara, Y; Ohno, S; Sugimachi, K; Takahashi, I1
Klein, J; Koren, G; Moselhy, G; Weitzman, S1
Adelstein, D; Bauer, L; Budd, GT; Bukowski, RM; Ganapathi, R; Gibson, V; McLain, D; Murthy, S; Sergi, J; Weick, J1
Coquery, L; Courjault, F; Leroy, D; Toutain, H1
Page, RL; Riviere, JE; Vaden, SL; Williams, PL1
Baur, M; Dittrich, C; Fazeny, B; Grunt, T; Hudec, M; Marth, C; Salzer, H; Sevelda, P; Vavra, N1
Bijnen, JH; Maes, RA; Rodenhuis, S; ten Bokkel Huinink, WW; van Tellingen, O; van Warmerdam, LJ1
Calvert, AH; Ghazal-Aswad, S; Newell, DR1
Rau, T; van Eldik, R1
Ma, J; Schellens, JH; Stoter, G; Verweij, J1
Chan, KK; Formenti, SC; Jeffers, S; Jozsef, G; Morrow, PC; Muggia, FM; Sapozink, M; Shrivastava, PN1
Akamo, Y; Manabe, T; Mizuno, I; Mohri, N; Shibata, T; Takeyama, H; Terada, J; Ueda, T; Yamamoto, T; Yotsuyanagi, T1
Hayashi, N; Ikeba, K; Kinoshita, K; Ohokubo, T; Sodemoto, T; Takagi, A; Takeda, S; Yamamoto, T1
Kimbara, K; Kunitoh, H; Nagatomo, A; Okamoto, H; Watanabe, K1
Bach, PH; Sharma, P1
Boven, E; Fichtinger-Schepman, AM; Korst, AE; van der Sterre, ML; van der Vijgh, WJ1
Bagarry-Liegey, D; Catalin, J; Duffaud, F; Durand, A; Favre, R; Guillet, P; Lacarelle, B; Monjanel, S; Nicoara, A1
Akaboshi, M; Kawai, K; Masunaga, S; Miyahara, T; Ono, K; Sumino, T; Tanaka, Y1
Hoshi, S; Mao, H; Nose, M; Orikasa, S; Suzuki, K; Takahashi, T1
Fluellen, L; Fusco, N; Rodriguez, M; Rose, PG1
Bachert, P; Becker, M; Port, RE; Zabel, HJ; Zeller, WJ1
Bench, G; Mauthe, RJ; Sideras-Haddad, E; Turteltaub, KW1
Apostoli, P; Bonetti, A; Cetto, GL; Colombatti, M; Franceschi, T; Leone, R; Pavanel, F; Sperotto, L; Zaninelli, M1
Bernhardt, G; Gust, R; Hummel, E; Koch, M; Krauser, R; Schmid, B; Schnurr, B; Schönenberger, H1
Helmers, E; Hubner, P; Kümmerer, K; Mascart, G; Milandri, M; Reinthaler, F; Zwakenberg, M1
Johannes, WU; Miller, GJ; Moffatt, KA1
Hamácek, J; Havel, J1
Heydorn, K; Krarup, C; Krarup-Hansen, A; Rietz, B; Rørth, M; Schmalbruch, H1
Appelius, H; Jaehde, U; Kloft, C; Schunack, W; Siegert, W1
al-Hussany, A; Ali, PA; el-Sharkawi, AM; Hancock, DA; Kadhim, R1
Agostino, M; Bartus, RT; Emerich, DF; Marsh, J; Perkins, A; Snodgrass, P1
Fujiwara, K1
Comerci, JT; Edwards, RP; Kanbour-Shakir, A; Kelley, JL; Kunschner, AJ; Price, FV; Sit, AS1
Fujiwara, K; Fujiwara, M; Ishikawa, H; Kohno, I; Suzuki, S; Tanaka, Y; Yamauchi, H1
Aiba, K; Akaza, H; Hoctin-Boes, G; Isonishi, S; Kawai, K; Konishi, T; Mikami, O; Miki, T; Noguchi, S; Ohashi, Y; Saeki, T; Saijo, N; Smith, M; Sone, S; Stribling, D; Tsukagoshi, S; Tsuruo, T1
Jun, MJ; Kim, KM; Kim, YS; Sohn, YS; Song, R1
Aghajanian, C; Dizon, DS; Hensley, ML; Hummer, A; Poynor, EA; Sabbatini, P; Spriggs, DR; Venkatraman, E1
Adjei, AA; Alberts, SR; Ames, MM; Atherton, P; Boemer, SA; Erlichman, C; Goldberg, RM; Hanson, LJ; Kaufmann, SH; Pitot, HC; Reid, JM; Ruben, S; Sloan, JA1
Greco, FA1
Goodisman, J; Hagrman, D; Souid, AK1
Carson, BS; Gillis, EM; Guarnieri, M; Jallo, GI; Johnson, RM; Kiely, A; Liu, YJ; Storm, P; Strege, RJ1
Holzer, AK; Howell, SB; Katano, K; Safaei, R; Samimi, G1
Goodman, M; Holzer, AK; Howell, SB; Katano, K; Rochdi, M; Safaei, R; Samimi, G; Tomioka, M1
Guo, Y; Petris, MJ; Smith, K1
Bailey, DB; Dykes, NL; Erb, HN; Hoopes, PJ; Page, RL; Rassnick, KM1
Chen, CL; Liang, LZ; Sun, MH; Tan, DC1
Sugiyama, T1
Chang, HM; Choi, SJ; Kang, YK; Kim, TW; Kim, WK; Lee, JS; Park, YH; Ryu, BY1
Au-Yeung, SC; Ho, YP; Li, KK; Pang, SK; Yu, CW1
Lautermann, J; Liedert, B; Seiler, F; Thomale, J; Thomas, JP1
Hotta, K; Kiura, K1
de Kroon, AI; de Kruijff, B; Hamelers, IH; Staffhorst, RW; van Loenen, E1
Beijnen, JH; Brouwers, EE; Hillebrand, MJ; Joerger, M; Rosing, H; Schellens, JH; Tibben, MM1
Collet, E; Coudert, B; Dalac, S; Jolimoy, G; Leguy-Seguin, V; Pernot, C; Vabres, P1
Alimonti, A; Bocca, B; Cappelli, C; Caroli, S; Clerico, A; De Ioris, MA; Petrucci, F; Ragni, G; Sordi, A1
Jett, JR; Keith, RL; Kesler, KA; Schild, SE1
Esteban-Fernández, D; Gómez-Gómez, MM; Palacios, MA; Ramírez-Camacho, R; Verdaguer, JM1
Carson, BS; Guarnieri, M; Jallo, GI1
Chen, X; Hou, S; Liu, W; Lou, L; Xie, M; Ye, Q; Yu, Y1
Blair, BG; Howell, SB; Larson, CA; Safaei, R1
Ito, K; Kaneyasu, Y; Komatsu, M; Nagai, N; Oshita, T; Shiroyama, Y; Watasaki, S1
Daneriallis, GM; Egorin, MJ; Goldman, S; Kondo, A; Mania-Farnell, B; Nakazaki, H; Rajaram, V; Soares, MB; Sredni, ST; Tange, Y; Tomita, T1
Arakawa, K; Ehara, S; Harada, S; Ishii, K; Ito, J; Kamiya, T; Matsuyama, S; Oikawa, S; Sato, T; Sera, K; Yamazaki, H; Yokota, W1
Aggarwal, S; Gambrell, RP; Hammer, RP; Ndinguri, MW; Solipuram, R1
Farshchi-Heydari, S; Howell, SB; Jandial, DD; Messer, K; Pu, M1
Bellanger, A; Caudron, E; Chappuy, M; Pradeau, D1
Fusch, EC; Holland, L; Krizanovic, O; Lax, PM; Lippert, B; Lutterbeck, M; Roitzsch, M; Sanz Miguel, PJ; Schürmann, M; Yin, L1
Arambula, JF; Fountain, ME; Magda, D; Sessler, JL; Siddik, ZH; Wei, WH1
Gumus, F; Ozkul, A; Serin, MS; Tezcan, S; Utku, S1
Eileen Dolan, M; Gamazon, E; Kistner-Griffin, EO; O'Donnell, PH; Stark, AL; Stephanie Huang, R; Zhang, W1
Ang, WH; Lippard, SJ; Myint, M1
Guan, Y; Lin, D; Liu, Y; Liu, Z; Ott, J; Shen, Y; Wu, C; Xu, B; Yu, D; Yuan, P1
Aavall-Lundqvist, E; Brown, C; du Bois, A; Ferrero, A; Gebski, V; Heywood, M; Jackisch, C; Joly, F; Kristensen, G; Le Fur, N; Lortholary, A; Pignata, S; Pujade-Lauraine, E; Sehouli, J; Vasey, PA; Vergote, I; Volgger, B; Wagner, U1
Alves, NJ; Berkowitz, J; Bilgicer, B; Chaudhuri, P; Chin, KT; Dinulescu, DM; Handlogten, MW; Mashelkar, RA; Muto, KW; Paraskar, AS; Sengupta, S; Soni, S1
Dvorák, Z; Starha, P; Trávnícek, Z; Vrzal, R1
Beijnen, JH; Brouwers, EE; de Vos, JP; Janssens, T; Schellens, JH2
Arimoto, T; Kawana, K; Nakagawa, S; Oda, K; Taketani, Y; Yasugi, T1
Chen, P; Cohen, EE; Cox, NJ; Das, S; Delaney, S; Dolan, ME; Gamazon, ER; Huang, RS; Im, HK; O'Donnell, PH; Shukla, S; Vokes, EE; Ziliak, D1
de Carvalho, LA; Marques, MP; Martin, C; Parker, SF; Tomkinson, J1
Berchuck, A; Havrilesky, LJ; Higgins, RV; Kohler, MF; Myers, ER; Nycum, LR; Pokrzywinski, R; Revicki, D; Secord, AA1
Aso, M; Ekimoto, H; Nakatake, H; Ogawa, A; Suemune, H; Yamaguchi, A1
Georgoulias, V; Pallis, AG1
Bandyopadhyay, D; Dabrowiak, JC; Luk, YY; Prashar, D; Shi, Y1
Alvarez Secord, A; Berchuck, A; Havrilesky, LJ; Higgins, RV; Holloway, RW; Kohler, MF; Lewandowski, GS; Nycum, LR; Puls, LE; Valea, FA1
Chen, X; Dong, C; Han, D; Li, C; Lin, H; Ren, S; Wang, X; Xu, C; Yang, S; Zhang, L; Zhang, Y; Zhao, D1
Avila, J; Cortés, P; Gill, M; Pizarro, I; Rivera, L; Román, DA; Torres, C1
Kotani, A; Kusu, F; Otsuki, Y1
Bonaventura, T; Brown, C; Fossati, R; Gebski, V; Heywood, M; Kaern, J; Largillier, R; Lauraine, EP; Marth, C; Piccirillo, MC; Vergote, I; Wagner, U1
de Carvalho, AL; Lopes, RP; Marques, MP; Matos, CS1
Chow, CW; Fujimoto, J; He, G; Kalhor, N; Kim, ES; Lee, JJ; Siddik, ZH; Stewart, DJ; Swisher, SG; Wistuba, II1
Brauckmann, C; Karst, U; Kieshauer, M; Lanvers-Kaminsky, C; Sperling, M; Wehe, CA1
Guan, ZZ; Guo, Y; Huang, H; Jiang, WQ; Li, S; Liao, H; Yang, XQ; Zhan, J; Zou, BY1
Duan, Z; He, C; Li, P; Xu, Q; Yuan, Y1
Galanski, MS; Jakupec, MA; Jensen, F; Keppler, BK; Roller, A; Varbanov, HP1
Beijnen, JH; Brouwers, EE; de Vos, JP; de Vries, N; Janssens, T; Schellens, JH2
Blackstock, AW; Bogart, JA; Crawford, J; Hodgson, L; Pang, H; Salama, JK; Schild, SE; Urbanic, JJ; Vokes, EE1
am Zehnhoff-Dinnesen, A; Langer, T; Meitert, J; Radtke, S; Zolk, O1
Nørøxe, DS; Sørensen, JB; Wallerek, S1
Chien, CT; Chiu, WC; Lin, SY; Liu, CY; Wu, TH; Yan, JY1
Eaddy, M; Green, MR; Gruschkus, SK; Peterson, P; Shah, M; Winfree, KB1
Aldrich-Wright, JR; Garbutcheon-Singh, KB; Harper, BW; Myers, S1
Ambriović-Ristov, A; Arany, I; Brozovic, A; Fiket, Z; Fritz, G; Köberle, B; Majhen, D; Osmak, M; Polančac, DS; Vuković, L1
Cemazar, M; Kovač, V; Martinčič, A; Milačič, R; Ščančar, J; Sersa, G1
Gómez-Gómez, MM; Mena, ML; Moreno-Gordaliza, E1
González, A1
Carty, MP; Cruet-Hennequart, S; Pasero, P; Sokol, AM1
Kumar, SJ; Madhavi, K; Manjusha, R; Meeravali, NN1
Au-Yeung, CF; Ho, YP; Pang, SK; So, WK1
Appleton, K; Brown, R; Gabra, H; Glasspool, RM; Gore, ME; Halford, SE; Hall, GD; Kaye, S; Mackean, M; McNeish, IA; Paul, J; Pledge, S; Rustin, GJ; Ullah, R; Walker, J; Wilson, RH1
Jangir, DK; Mehrotra, R1
Açık, L; Arsoy, T; Celebi Keskin, A; Gümüş, F; Ozçelik, AB; Utku, S; Yılmaz, S1
Li, KM; Tong, LX; Xiao, P; Xie, D; Yin, RT1
Gan, B; Huang, Y; Liao, R; Lou, N; Wu, Y; Xu, C; Yan, H; Yang, J; Yang, X; Yang, Y; Zhou, Q1
Esteban-Fernández, D; Gómez-Gómez, MM; Linscheid, MW; Mena, ML; Moraleja, I; Moreno-Gordaliza, E1
Bamias, A; Dimopoulos, MA; Episkopou, H; Gavalas, N; Kalampokas, T; Kyrtopoulos, SA; Likka, M; Photiou, S; Sfikakis, PP; Souliotis, VL; Stefanou, DT1
Bremnes, RM; Brydøy, M; Fosså, SD; Gundersen, PO; Haugnes, HS; Hjelle, LV; Oldenburg, J; Tandstad, T; Wilsgaard, T1
Aftimos, PG; Awada, A; Bartholomeus, S; Berghmans, T; Cescutti, J; Costermans, J; Dumez, H; Forceville, K; Liu, D; Meeus, MA; Munzert, G; Pilz, K; Schöffski, P1
Chen, YM; Lee, YC; Lin, YH; Perng, RP; Tseng, YC; Tseng, YH; Whang-Peng, J1
Wang, Z; Xu, Z; Yiu, SM; Zhu, G1
Galanski, MS; Göschl, S; Jakupec, MA; Keppler, BK; Theiner, S; Varbanov, HP1
Hu, Z; Sun, C; Wang, W; Yao, H1
Alard, A; Blank, SV; Curtin, JP; David-West, G; Musa, F; Schneider, RJ1
Bamias, A; Chatziioannou, A; Dimopoulos, MA; Gavalas, NG; Haidopoulos, D; Kostouros, E; Koutsoukos, K; Liontos, M; Lykka, M; Papadodima, O; Pilalis, E; Rodolakis, A; Terpos, E; Thomakos, N; Trachana, SP; Tzannis, K; Vlachos, G1
Chan, C; Duan, X; Han, W; Lin, W; Poon, C1
Altwerger, G; Azodi, M; Carusillo, N; English, DP; Gressel, GM; Nelson, WK; Ratner, ES; Santin, A; Schwartz, PE; Silasi, DA1
Dirikolu, L; Garrett, LD; Mitchell, MA; Phillips, H; Tulipan, RJ2
Ab, O; Bartle, LM; Coccia, J; Lanieri, L; Lee, J; Pinkas, J; Ponte, JF; Ruiz-Soto, R; Themeles, M; Zhou, Y1
Airhart, S; Chamie, K; Cimino, GD; de Vere White, R; Drakaki, A; Haack, K; Henderson, PT; Lin, TY; Malfatti, M; Ognibene, T; Pan, CX; Tepper, CG; Turteltaub, KW; Wang, SS; Yang, H; Zhang, H; Zimmermann, M1
Hummon, AB; Liu, X1
Anisimov, VN; Drobyshev, EJ; Fedoros, EI; Ivanenko, NB; Panchenko, AV; Pigarev, SE; Solovyev, ND; Tyndyk, ML; Vilpan, YA1
Hyman, DM; Iasonos, A; Schram, AM1
Boon, N; De Smet, R; Fitts, JP; Hennebel, T; Maes, S; Props, R; Vanhaecke, F1
McQuade, R; Nurgali, K; Rybalka, E; Stojanovska, V1
Afghahi, A; Carlson, RW; Chang, PJ; Ford, JM; Hartman, AR; Jensen, KC; Kurian, AW; Schackmann, E; Telli, ML; Timms, KM; Vinayak, S1
Han, ZG; Shan, L; Tao, J; Yu, TT1
Amato, LB; Bucci, C; Dusi, S; Gasparre, G; Girolimetti, G; Guerra, F; Iommarini, L; Kurelac, I; Leone, G; Maffia, M; Perrone, AM; Porcelli, AM; Tiranti, V; Vergara, D; Vidone, M1
Dewkar, GK; Lamichhane, N; Mahon, RN; Sundaresan, G; Zweit, J1
Gao, H; He, K; Li, L; Li, X; Liu, X; Qin, H; Qu, L; Tang, C; Wang, L; Wang, W; Xu, B; Yang, L1
Adam, V; Brtnicky, M; Eckschlager, T; Hubalek, J; Kynicky, J; Smerkova, K; Stiborova, M; Vaculovic, T; Vaculovicova, M1
Chen, F; Gou, S; Jin, X; Zhao, J1
Hayashi, R; Hayashi, Y; Koide, T; Masuda, R; Nose, H; Taguchi, A; Yasui, H1
Cheung, S; Griffith, DM; Kitteringham, E; O'Shea, DF; Twamley, B; Wu, D1
Curigliano, G1
Hamada, N; Nakanishi, Y; Okamoto, I; Otsubo, K1
Hashimoto, H; Kontani, K; Mimura, M; Miyatake, T; Nagamatsu, M; Nishikawa, A; Takeda, M; Yokoi, T1
Alamgeer, M; Barrow, R; Boolell, V; Burgess, A; Cain, JE; Chin, V; Croucher, DR; de Kretser, DM; Ganju, V; Gonzalez-Rajal, A; Han, JZR; Harrison, CA; Hastings, JF; Hedger, MP; Jayasekara, WSN; Kita, B; Kostyrko, K; Kumar, B; Lee, HC; Lorensuhewa, N; Marini, KD; Marquez, C; Martelotto, LG; McCloy, RA; Oakes, SR; Robinson, BW; Rossello, FJ; Sweet-Cordero, EA; Szczepny, A; Vaghjiani, V; Watkins, DN; Waugh, T; Wu, J1
DeYonker, NJ; Duplanty, M; Khan, S; Lozano, HC; Mirsaleh-Kohan, N; Morris, TJ; Nguyen, T; Rostovtsev, YV; Torres, M1
Fan, TM; Maxwell, EA; Phillips, H; Schaeffer, DJ1
de Vere White, R; Henderson, PT; Malfatti, MA; Pan, CX; Scharadin, TM; Turteltaub, KW; Wang, S; Zimmermann, M1
Berkowitz, B; Dror, I; Goykhman, N1
Brooks, B; Carleton, B; Clemens, E; de Vries, ACH; van den Heuvel-Eibrink, MM; van Grotel, M1
Arnaiz, MD; Aso, S; Bergamino, M; Brao, I; Cardenal, F; Montanya, E; Nadal, E; Navarro, A; Padrones, S; Palmero, R; Peiró, I; Ruffinelli, JC; Rullan, AJ; Saigí, M1
Eskandari, A; Ghosh, S; Kundu, A; Suntharalingam, K1
Ciofi, L; Cirri, D; Fabbrini, MG; Marzo, T; Massai, L; Messori, L; Pratesi, A1
Adjei, AA; Aubry, MC; Bertino, E; Dakhil, SR; Dy, GK; Lee Hann, C; Mandrekar, SJ; Molina, JR; Nieva, JJ; Sachs, BA; Schenk, EL; Schild, SE; Tan, AD; Wadsworth, TW1
Al-Chamali, H; Bird, T; Cox, C; Dorey, N; Gomberg, S; Goody, R; Hingorani, M; Hurt, C; Macgregor, U; Mukherjee, S; Owens, R; Pan, S; Parikh, S; Prince, S; Radhakrishna, G1
Ishiki, H; Kiuchi, D; Kubo, E; Satomi, E; Shimizu, M; Tanaka, T; Yokota, S1
Clark-Price, SC; Fan, TM; Maxwell, EA; Phillips, H; Schaeffer, DJ; Selmic, LE; Vieson, MD1
Burotto, M; Caglevic, C; Cortés Fuentes, IA; Frelinghuysen, M; Gormaz, JG; Retamal, MA1
Adawi, R; Gopas, J; Khamaisi, H; Koren Carmi, Y; Mahajna, J; Mahmoud, H1
Alcaraz-Sanabria, A; Burgos, M; Corrales-Sanchez, V; Galan-Moya, EM; Martinez-Canales, S; Montero, JC; Nieto-Jimenez, C; Nuncia-Cantarero, M; Ocaña, A; Pandiella, A1
Lynce, F; Nunes, R1
Hoare, JI; Lockley, M; Martin, SA; Metcalf, S; Nicolini, F; Saxena, J; Silva, VL1
Fujiwara, H; Fujiwara, K; Kanuma, T; Nakamura, K; Nakamura, Y; Sakurai, M; Satoh, T; Suzuki, M; Takahashi, S; Takei, Y1
Fujishiro, H; Hamao, S; Himeno, S; Sumi, D; Taguchi, H1
Apaijai, N; Charoenkwan, K; Chattipakorn, N; Chattipakorn, SC; Jaiwongkam, T; Khunamornpong, S; Kingnate, C; Kumfu, S1
Han, XH; Liu, S; Shi, YY; Yang, R1
Kim, HS; Lee, M; Lee, N; Lee, S; Paik, H; Park, SJ; Yim, GW1
Chawla, PA; Sharma, R; Singh, VJ1
Belda, B; Messenger, KM; Ramos-Vara, J; Risselada, M1
Cadoo, KA; Chambers, SK; Chen, LM; Chmielecki, J; Cragun, JM; Geenen, JJJ; Ghamande, SA; Hamilton, EP; Jones, SF; Konecny, GE; Kumar, S; Lai, Z; Moore, KN; Mugundu, GM; Oza, AM; Plaxe, SC; Rodrigo Imedio, E; Spigel, DR; Spitz, DL; Troso-Sandoval, TA1
Abdel-Rahman, O; Koski, SL1
Hirayama, Y; Kato, M; Kuratsukuri, K; Otoshi, T; Takeyama, Y; Uchida, J; Yamamoto, S; Yamasaki, T; Yukimatsu, N1
Katsuda, T; Matsukuma, K; Nasu, H; Nishio, S; Park, J; Tasaki, K; Terada, A; Tsuda, N; Ushijima, K; Yoshimitsu, T1
Brigato, F; De Corso, E; Fetoni, AR; Galli, J; Lucidi, D; Ruggiero, A; Scarano, E; Sergi, B1
Gao, X; Xu, C; Yao, Q; Zhang, C1
Crabb, SJ; Hack, J1
Chen, S; Deng, Z; Liu, G; Shi, J; Wang, N; Wang, Z; Yao, H; Zhou, J; Zhu, G1
Hu, Z; Liao, J; Liu, C; Sun, S; Wang, H; Wang, J; Wu, X; Yu, H; Zhang, Y; Zhao, X1
Bignotti, E; Bugatti, M; Calza, S; Capoferri, D; Lonardi, S; Odicino, F; Pijnenborg, JMA; Ratti, M; Ravaggi, A; Reijnen, C; Romani, C; Sartori, E; Tognon, G; Zanotti, L1
Cheong, TF; Chiang, KY; Ho, JCM; Ip, MSM; Kwok, WC; Lam, DCL; Tam, TCC1
Abu-Hejleh, T; Allen, BG; Bellizzi, AM; Bodeker, KL; Bossler, AD; Buatti, JM; Buettner, GR; Byrne, MM; Cullen, JJ; Fath, MA; Furqan, M; Hartwig, SM; Henrich, JB; Houtman, JC; Ivanovic, M; Mani, H; Monga, V; Mott, SL; Petronek, M; Pulliam, CF; Smith, BJ; Spitz, DR; Stephens, LM; Varga, SM; Wagner, BA; Zeitler, W; Zhang, J1
Jalili, A; Kinaciyan, T; Marquart, E; Mothes-Luksch, N; Wagner, SN1
Boellaard, TN; de Feijter, JM; Einerhand, SMH; Hendricksen, K; Schaake, EE; van de Kamp, MW; van der Heijden, MS; van Dijk, N; van Dorp, J; van Montfoort, ML; van Rhijn, BWG1
Berretta, M; Cocetta, V; Giacomini, I; Montopoli, M; Ragazzi, E; Rosato, B; Tinazzi, M1
Am Zehnhoff-Dinnesen, A; Ansari, M; Kompis, M; Kuehni, CE; Mader, L; Parfitt, R; Sláma, T; Strebel, S; von der Weid, NX; Waespe, N; Weiss, A1
Chadha, S; Dillard, LK; Fullerton, AM; Lopez-Perez, L; Martinez, RX; McMahon, CM1
Clarke, RG; Ferguson, MJ; Hiom, KJ; Nicholson, HA; Sawers, L; Smith, G1
Alassadi, S; Pisani, MJ; Wheate, NJ1
Anari, F; Geynisman, DM; Ghatalia, P; Handorf, E; Miron, B; Plimack, ER; Zarrabi, K; Zibelman, MR1
He, ZY; Li, DC; Li, HY; Li, SJ; Liang, ZZ; Yan, J1
Balakrishnan, AJ; Janardhanan, P; Pilankatta, R; Somasundaran, AK1
Graham, TA; Haughey, MJ; Hoare, JI; Hockings, H; Huang, W; Lockley, M; Maniati, E; McNeish, IA; Mirza, H; Nicolini, F; Saxena, J; Silva, VL; Wood, GE1
Alessio, E; Burckel, P; Gandioso, A; Gasser, G; Vidal, A1
Berger, J; Boisen, M; Buckanovich, R; Coffman, LG; Courtney-Brooks, M; Edwards, RP; Frisbie, LG; Griffith, K; Lesnock, J; Liu, T; Mahdi, H; McLean, K; Normolle, D; Olawaiye, A; Orellana, TJ; Sukumvanich, P; Taylor, SE; Uppal, S1
Cao, L; Fan, Y; Fang, J; He, J; Hu, J; Liu, W; Liu, Y; Lu, S; Shi, J; Wang, Z; Xia, J; Yi, J; Zhou, J1
Imai, H; Kaburagi, T; Kagamu, H; Kaira, K; Kanazawa, K; Kishikawa, T; Masubuchi, K; Minato, K; Minemura, H; Nagai, Y; Shiihara, J; Shiono, A; Takechi, H; Taniguchi, H; Tsuda, T; Umeda, Y; Wasamoto, S; Yamada, Y1
Barletta, JA; Bosma-Moody, A; Camp, S; Carey, E; Conway, J; Crowdis, J; Dietlein, F; Han, S; He, MX; Huang, J; Imamovic, A; Kofman, E; Liu, D; Lorch, JH; Pappa, T; Park, J; Reardon, B; Schiantarelli, J; Shannon, E; Stanizzi, D; Van Allen, EM1
Chen, L; Chen, Y; Deng, P; Dong, Y; Han, B; Kong, T; Liu, D; Qian, F; Yang, H; Zhang, B; Zhang, W; Zhang, Y1
Aldrich-Wright, JR; Aputen, AD; Elias, MG; Gilbert, J; Gordon, CP; Sakoff, JA; Scott, KF1
Arenare, L; Artioli, G; Baldassarre, G; Beltrame, L; Califano, D; Campanini, N; Capoluongo, ED; Cecere, SC; Chiodini, P; Cinieri, S; Colombo, N; D'Incalci, M; De Cecio, R; Llop-Guevara, A; Lorusso, D; Marchini, S; Mezzanzanica, D; Musolino, A; Nardelli, C; Normanno, N; Pellegrino, B; Perrone, F; Pignata, S; Pisano, C; Roma, C; Russo, D; Scaglione, GL; Scambia, G; Sergi, A; Serra, V; Setaro, M; Spina, A; Tasca, G1
Aderibigbe, BA; Alven, S; Buyana, B; Naki, T1
Enzinger, PC; Guo, H; Joo, S; Meng, Y; Qu, T; Zhang, S; Zhong, Y1
Cheng, Y; Cui, J; Lin, C; Peng, Z; Qian, K; Wu, R; Yin, W1
Ahmed, R; Attia, M; Hanna, D; Kamal, NM; Oshi, MAM; Rifky, E; Sherief, LM1
Ahmed, N; Goonetilleke, L; Kadife, E; Kannourakis, G; Leung, D; Lokman, NA; Oehler, MK; Price, ZK; Ricciardelli, C; Wang, W1
de Korte-Grimmerink, R; Decollogny, M; Domanitskaya, N; Essers, P; Fendler, W; Galván, JA; Howald, D; Huijbers, IJ; Klebic, I; Nowicka, Z; Pritchard, CEJ; Rottenberg, S; Siffert, M; Stokar-Regenscheit, N; van de Ven, M; Vens, C; Widmer, CA1
Akeroyd, MA; Baguley, DM; Pearson, SE; Phillips, OR1
Czeleń, P; Szefler, B1
Akerley, W; Haaland, B; Kerrigan, K; Patel, S; Puri, S; Sama, S; Sinnott, JA1
Aglietta, M; Arcangeli, V; Barretina-Ginesta, MP; Benedetti Panici, P; Berger, R; Biagioli, E; Bologna, A; Chekerov, R; Churruca Galaz, C; Colombo, N; D'Incalci, M; De Giorgi, U; DeCensi, A; Deryal, M; Fossati, R; Funari, G; Gadducci, A; Heinzelmann-Schwarz, V; Herbertson, R; Iglesias, M; Mäenpää, J; Mirza, MR; Montes, A; Nyvang, GB; Ottevanger, NB; Pardo, B; Poveda, A; Riniker, S; Romeo, M; Rubio-Pérez, MJ; Rulli, E; Sehouli, J; Sessa, C; Tasca, G; Tognon, G; Tsibulak, I; Vergote, I; Westermann, A; Wimberger, P; Zamagni, C; Zola, P1
Adamo, V; Cantale, O; Castorina, L; Chillari, F; Colarossi, C; Esposito, F; Franchina, T; Giuffrida, D; Puliafito, I; Ricciardi, GRR; Russo, A; Sciacca, D; Vitale, MP1
Eom, JS; Jo, EJ; Kim, KU; Kim, MH; Kim, SH; Lee, K; Lee, MK; Mok, J; Park, HK1
Han, Z; Hong, Z; Li, S; Qin, Y; Wang, L; Wang, X; Zhu, D1
Abe, M; Aida, T; Baba, T; Chiba, Y; Kagabu, M; Kaido, Y; Nagasawa, T; Shoji, T; Takahashi, F; Takatori, E1
Endo, J; Fujii, H; Fukui, M; Gomyo, T; Hirose, C; Iihara, H; Inui, T; Kaito, D; Kawae, D; Kinomura, M; Kitamura, YU; Kobayashi, R; Ohno, Y; Sakai-Masuda, C; Sasaki, Y; Suzuki, A; Yanase, K1
Albertella, MR; Bani, MR; Decio, A; Dellavedova, G; Formenti, L; Ghilardi, C; Giavazzi, R; Leo, E; Staniszewska, AD; Wilson, J1
Bonomo, P; Borcoman, E; Cau, MC; Depenni, R; Ghi, MG; Ghiani, M; Le Tourneau, C; Leo, L; Messinger, D; Montesarchio, V; Ronzino, G; Salmio, S; Sbrana, A; Schulten, J1
Artaç, M; Bozcuk, H; Eser, İ; Mutlu, H1
Bleckmann, A; Frost, N; Griesinger, F; Grohé, C; Janning, M; Kollmeier, J; Reck, M; Reinmuth, N; Sebastian, M; Thomas, M1
Adawi, R; Gopas, J; Khamaisi, H; Koren Carmi, Y; Mahajna, J; Noyman, E1
Borgonovo, K; Celotti, A; Ghidini, A; Lorusso, D; Luciani, A; Petrelli, F; Rea, CG; Solinas, C; Villa, A1
Enamorado, Y; Han, D; López-Mesas, M; Luaces, M; Melchior, A; Sanadar, M; Valiente, M1
Gu, X; Guan, Y; Hao, Y; Song, Z; Sun, Y; Wang, W; Xiang, J; Yao, Q; Zeng, X1
Bhanegaonkar, A; Bilen, MA; Kim, R; Liu, FX; Peng, J; Robinson, SB; Schroeder, A1
Augusto, I; Cruz, A; Mansinho, A; Marconi, L; Pinto, C1
Akamatsu, H; Hida, T; Inui, N; Kang, JH; Kim, HR; Lee, JS; Lee, KH; Nakagawa, K; Nishio, M; Ohe, Y; Sugawara, S; Takahashi, S; Tamura, T; Tanaka, H; Yamamoto, N; Yang, CT; Yoshida, T; Yu, CJ1
Chiavarino, B; Corinti, D; Crestoni, ME; Fornarini, S; Rotari, L; Salpin, JY; Scuderi, D1
Cedrés, S; Hansen, TB; Herrera-Juarez, M; Isambert, N; Jaderberg, M; Lederlin, M; Levitsky, V; Martinez-Marti, A; Navarro, A; Paz-Ares, L; Ponce, S; Ricordel, C; Serres, X; Vetrhus, S; Viteri, S; Zugazagoitia, J1
Beith, J; Dear, RF; Egger, SJ; Goodwin, A; Mason, SR; Willson, ML1
Aiba, T; Domeki, Y; Kawana, S; Kawashima, Y; Kimura, Y; Nakamura, A; Sugawara, S; Sugisaka, J; Toi, Y; Yamanda, S1
Cormier, L; Lui, S; Middleton, L; Ndinguri, M; Nienaber, E; Rollins, J; Spease, C; Unrine, J; Williams, A1
Hara, Y; Hashimoto, H; Horita, N; Kaneko, A; Kaneko, T; Kobayashi, N; Kubo, S; Kudo, M; Matsumoto, H; Somekawa, K; Teranishi, S; Watanabe, K1
Ahn, S; Bao, K; Choi, HS; Kang, H; Kim, J; Park, SH; Stiles, WR; Yamashita, A; Zeng, L1
Abro, MI; Jahangir, TM; Khaskheli, MA; Khaskheli, MI; Khokhar, FM; Khokhar, LA; Khuhawar, MY; Muqaddisa, P1
Aoyagi, K; Boonstra, E; Cabral, H; Hong, T; Ono, R; Perkins, EJ; Quader, S; Sasaki, H; Tanabe, S; Yokozaki, H1

Reviews

30 review(s) available for platinum and carboplatin

ArticleYear
Clinical pharmacokinetics of carboplatin.
    Clinical pharmacokinetics, 1991, Volume: 21, Issue:4

    Topics: Administration, Oral; Animals; Blood Proteins; Bone Marrow; Carboplatin; Cisplatin; Humans; Injections, Intraperitoneal; Injections, Intravenous; Neoplasms; Platinum; Protein Binding; Tissue Distribution

1991
Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group.
    BMJ (Clinical research ed.), 1991, Oct-12, Volume: 303, Issue:6807

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Female; Humans; Infant, Newborn; Meta-Analysis as Topic; Ovarian Neoplasms; Platinum; Randomized Controlled Trials as Topic; Survival Rate

1991
Carboplatin as a potentiator of radiation therapy.
    Cancer treatment reviews, 1985, Volume: 12 Suppl A

    Topics: Animals; Antineoplastic Agents; Carboplatin; Combined Modality Therapy; Cricetinae; Cricetulus; Humans; Mice; Neoplasms; Organoplatinum Compounds; Platinum; Radiation-Sensitizing Agents

1985
Platinum resistance: laboratory findings and clinical implications.
    Stem cells (Dayton, Ohio), 1993, Volume: 11, Issue:3

    Topics: Animals; Carboplatin; Cisplatin; Drug Resistance; Humans; Platinum

1993
Mechanistic insight from kinetic studies on the interaction of model palladium (II) complexes with nucleic acid components.
    Metal ions in biological systems, 1996, Volume: 32

    Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Drug Design; Humans; Kinetics; Neoplasms; Nucleosides; Nucleotides; Palladium; Platinum; Purines; Pyrimidines

1996
[Platinum compounds in cancer therapy--past, present, and future].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Forecasting; Humans; Irinotecan; Medical Oncology; Neoplasms; Organoplatinum Compounds; Oxaliplatin; Platinum

2001
[Second-line chemotherapy for recurrent ovarian cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclophosphamide; Docetaxel; Doxorubicin; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Irinotecan; Ovarian Neoplasms; Paclitaxel; Platinum; Taxoids

2005
Is there a standard regimen for first-line treatment of advanced/metastatic Non-Small-Cell Lung Cancer? What has meta-analyses contributed to today's standard of care.
    Lung cancer (Amsterdam, Netherlands), 2012, Volume: 75, Issue:3

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Humans; Lung Neoplasms; Meta-Analysis as Topic; Platinum; Standard of Care

2012
New strategies against prostate cancer--Pt(II)-based chemotherapy.
    Current medicinal chemistry, 2012, Volume: 19, Issue:27

    Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Drug Delivery Systems; Drug Resistance, Neoplasm; Drug Therapy, Combination; Humans; Male; Organoplatinum Compounds; Oxaliplatin; Platinum; Prostatic Neoplasms

2012
Understanding platinum-induced ototoxicity.
    Trends in pharmacological sciences, 2013, Volume: 34, Issue:8

    Topics: Animals; Antineoplastic Agents; Carboplatin; Child; Cisplatin; Ear Diseases; Humans; Neoplasms; Platinum; Quality of Life; Risk Factors

2013
Increasing the chances for platinum-sensitive ovarian cancer patients.
    Future oncology (London, England), 2013, Volume: 9, Issue:12 Suppl

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dioxoles; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Ovarian Neoplasms; Platinum; Polyethylene Glycols; Recurrence; Tetrahydroisoquinolines; Trabectedin; Treatment Outcome

2013
The role of annexin A4 in cancer.
    Frontiers in bioscience (Landmark edition), 2016, 06-01, Volume: 21, Issue:5

    Topics: Annexin A4; Calcium; Carboplatin; Chlorides; Copper-Transporting ATPases; Drug Resistance, Neoplasm; Female; Gene Knockdown Techniques; Humans; Male; Neoplasms; NF-kappa B; Platinum; Up-Regulation

2016
Neurotoxicity Associated with Platinum-Based Anti-Cancer Agents: What are the Implications of Copper Transporters?
    Current medicinal chemistry, 2017, Volume: 24, Issue:15

    Topics: Adenosine Triphosphatases; Antineoplastic Agents; Carboplatin; Cation Transport Proteins; Cisplatin; DNA Adducts; Humans; Neoplasms; Neurons; Organoplatinum Compounds; Oxaliplatin; Platinum

2017
Anticancer drug treatment for advanced lung cancer with interstitial lung disease.
    Respiratory investigation, 2018, Volume: 56, Issue:4

    Topics: Albumins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Disease Progression; Etoposide; Follow-Up Studies; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Paclitaxel; Platinum; Retrospective Studies; Risk Assessment; Risk Factors

2018
Outcome of Weekly Carboplatin-Paclitaxel-based Definitive Chemoradiation in Oesophageal Cancer in Patients Not Considered to be Suitable for Platinum-Fluoropyrimidine-based Treatment: A Multicentre, Retrospective Review.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2020, Volume: 32, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Paclitaxel; Platinum; Prospective Studies; Retrospective Studies

2020
Role of Platinums in Triple-Negative Breast Cancer.
    Current oncology reports, 2021, 03-22, Volume: 23, Issue:5

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Humans; Neoadjuvant Therapy; Platinum; Triple Negative Breast Neoplasms

2021
The Impact of Platinum-Containing Chemotherapies in Advanced Triple-Negative Breast Cancer: Meta-Analytical Approach to Evaluating Its Efficacy and Safety.
    Oncology research and treatment, 2021, Volume: 44, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Humans; Platinum; Progression-Free Survival; Triple Negative Breast Neoplasms

2021
Advancements in the Use of Platinum Complexes as Anticancer Agents.
    Anti-cancer agents in medicinal chemistry, 2022, Volume: 22, Issue:5

    Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Humans; Neoplasms; Oxaliplatin; Platinum

2022
Platinum-based drugs for cancer therapy and anti-tumor strategies.
    Theranostics, 2022, Volume: 12, Issue:5

    Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Humans; Neoplasms; Oxaliplatin; Platinum

2022
Clinical Evidence of Interaction between Nutraceutical Supplementation and Platinum-based Chemotherapy.
    Current medicinal chemistry, 2023, Volume: 30, Issue:19

    Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Dietary Supplements; Humans; Platinum; Quality of Life

2023
Global burden of ototoxic hearing loss associated with platinum-based cancer treatment: A systematic review and meta-analysis.
    Cancer epidemiology, 2022, Volume: 79

    Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Hearing Loss; Humans; Neoplasms; Ototoxicity; Platinum

2022
A chemical perspective on the clinical use of platinum-based anticancer drugs.
    Dalton transactions (Cambridge, England : 2003), 2022, Jul-26, Volume: 51, Issue:29

    Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Humans; Oxaliplatin; Platinum

2022
Nanoparticles Loaded with Platinum Drugs for Colorectal Cancer Therapy.
    International journal of molecular sciences, 2022, Sep-24, Volume: 23, Issue:19

    Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Colorectal Neoplasms; Female; Humans; Male; Nanoparticles; Organoplatinum Compounds; Oxaliplatin; Platinum

2022
Efficacy of platinum-based and non-platinum-based drugs on triple-negative breast cancer: meta-analysis.
    European journal of medical research, 2022, Oct-15, Volume: 27, Issue:1

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Estrogens; Humans; Platinum; Randomized Controlled Trials as Topic; Receptors, Progesterone; Triple Negative Breast Neoplasms

2022
The long-term impacts of hearing loss, tinnitus and poor balance on the quality of life of people living with and beyond cancer after platinum-based chemotherapy: a literature review.
    Journal of cancer survivorship : research and practice, 2023, Volume: 17, Issue:1

    Topics: Adult; Antineoplastic Agents; Cancer Survivors; Carboplatin; Child; Cisplatin; Hearing Loss; Humans; Neoplasms; Ototoxicity; Platinum; Quality of Life; Tinnitus

2023
Will the Interactions of Some Platinum (II)-Based Drugs with B-Vitamins Reduce Their Therapeutic Effect in Cancer Patients? Comparison of Chemotherapeutic Agents such as Cisplatin, Carboplatin and Oxaliplatin-A Review.
    International journal of molecular sciences, 2023, Jan-12, Volume: 24, Issue:2

    Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Humans; Neoplasms; Organoplatinum Compounds; Oxaliplatin; Platinum; Vitamin B Complex

2023
First-line immune-checkpoint inhibitor treatment in extensive-disease small-cell lung cancer: A classical and network meta-analysis.
    Journal of cancer research and therapeutics, 2023, Volume: 19, Issue:Supplement

    Topics: Antineoplastic Agents, Immunological; B7-H1 Antigen; Carboplatin; Etoposide; Humans; Immune Checkpoint Inhibitors; Lung Neoplasms; Network Meta-Analysis; Platinum; Programmed Cell Death 1 Receptor; Small Cell Lung Carcinoma

2023
Treatments for relapsed, BRCA-wild type, platinum-sensitive ovarian cancer: A systematic review and network meta-analysis.
    Cancer treatment reviews, 2023, Volume: 118

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Ovarian Epithelial; Doxorubicin; Female; Humans; Neoplasm Recurrence, Local; Network Meta-Analysis; Ovarian Neoplasms; Platinum; Polyethylene Glycols

2023
Avelumab as First-Line Maintenance Treatment in Locally Advanced or Metastatic Urothelial Carcinoma.
    Advances in therapy, 2023, Volume: 40, Issue:10

    Topics: B7-H1 Antigen; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Disease Progression; Humans; Immune Checkpoint Inhibitors; Neoplasm Recurrence, Local; Platinum; Urinary Bladder Neoplasms

2023
Platinum-based chemotherapy for early triple-negative breast cancer.
    The Cochrane database of systematic reviews, 2023, 09-08, Volume: 9

    Topics: Adjuvants, Immunologic; Anthracyclines; Carboplatin; Febrile Neutropenia; Humans; Platinum; Quality of Life; Triple Negative Breast Neoplasms

2023

Trials

41 trial(s) available for platinum and carboplatin

ArticleYear
Dose-escalation study of carboplatin (day 1) and cisplatin (day 3): tolerance and relation to leukocyte and buccal cell platinum--DNA adducts.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cheek; Cisplatin; DNA; Drug Administration Schedule; Drug Evaluation; Female; Hematologic Diseases; Humans; Leukocytes; Male; Middle Aged; Mouth Mucosa; Platinum

1991
Platinum-DNA damage in leukocyte DNA of patients receiving carboplatin and cisplatin chemotherapy, measured by atomic absorption spectrometry.
    Carcinogenesis, 1991, Volume: 12, Issue:7

    Topics: Carboplatin; Cisplatin; DNA; DNA Damage; Double-Blind Method; Drug Administration Schedule; Female; Humans; Leukocytes; Male; Neoplasms; Platinum; Prospective Studies; Spectrophotometry, Atomic

1991
A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:5

    Topics: Adult; Antineoplastic Agents; Bone Marrow Transplantation; Carboplatin; Clinical Trials as Topic; Combined Modality Therapy; Drug Evaluation; Female; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Organoplatinum Compounds; Platinum

1989
Comparison of platinum concentrations in human head and neck tumours following administration of carboplatin, iproplatin or cisplatin.
    Bulletin du cancer, 1987, Volume: 74, Issue:4

    Topics: Adult; Antineoplastic Agents; Carboplatin; Cisplatin; Head and Neck Neoplasms; Humans; Middle Aged; Organoplatinum Compounds; Platinum

1987
[Pharmacokinetic analysis of platinum in the continuous CDDP-CBDCA treatment; its relation to the changes of blood biochemistry].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carboplatin; Cisplatin; Creatinine; Drug Administration Schedule; Endometrial Neoplasms; Female; Humans; Infusions, Intravenous; Platinum; Uterine Neoplasms

1995
A dosing scheme for carboplatin in adult cancer patients based upon pre-infusion renal function and platelet count.
    Anti-cancer drugs, 1994, Volume: 5, Issue:5

    Topics: Adenocarcinoma; Aged; Carboplatin; Dose-Response Relationship, Drug; Female; Glomerular Filtration Rate; Humans; Kidney Function Tests; Male; Middle Aged; Monte Carlo Method; Ovarian Neoplasms; Platelet Count; Platinum; Risk Factors; Teratoma; Testicular Neoplasms; Thrombocytopenia

1994
Phase I study of WR-2721 and carboplatin.
    European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:8

    Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Platinum; Thrombocytopenia

1993
In vitro and in vivo evaluation of the combination of cisplatin and its analogue carboplatin for platinum dose intensification in ovarian carcinoma.
    Cancer, 1993, May-15, Volume: 71, Issue:10

    Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Dose-Response Relationship, Drug; Female; Humans; Leukocyte Count; Ovarian Neoplasms; Pilot Projects; Platelet Count; Platinum; Tumor Cells, Cultured

1993
Monitoring carboplatin concentrations in saliva: a replacement for plasma ultrafiltrate measurements?
    Therapeutic drug monitoring, 1995, Volume: 17, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Carboplatin; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Injections, Intravenous; Male; Middle Aged; Platinum; Reproducibility of Results; Saliva; Spectrophotometry, Atomic

1995
[Clinical effect of intra-arterial carboplatin-combined chemotherapy for advanced uterine cervical cancer and increased tissue platinum levels with Lipo PGE1 administration before chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:12

    Topics: Adenocarcinoma; Adult; Aged; Alprostadil; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cervix Uteri; Chemotherapy, Adjuvant; Epirubicin; Etoposide; Female; Humans; Iliac Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Middle Aged; Mitomycin; Platinum; Uterine Cervical Neoplasms; Vindesine

1996
Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1996, Volume: 2, Issue:11

    Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Cisplatin; DNA Adducts; Female; Humans; Leukocytes, Mononuclear; Male; Mass Spectrometry; Middle Aged; Neoplasms; Platinum

1996
Histology and platinum content of sensory ganglia and sural nerves in patients treated with cisplatin and carboplatin: an autopsy study.
    Neuropathology and applied neurobiology, 1999, Volume: 25, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Agents; Autopsy; Carboplatin; Cisplatin; Dose-Response Relationship, Drug; Female; Ganglia, Spinal; Humans; Male; Middle Aged; Platinum; Sural Nerve

1999
A phase I and pharmacologic study of pyrazoloacridine (NSC 366140) and carboplatin in patients with advanced cancer.
    Investigational new drugs, 2002, Volume: 20, Issue:3

    Topics: Acridines; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; DNA Adducts; Drug Interactions; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Platinum; Pyrazoles

2002
Phase II study of paclitaxel and carboplatin in advanced gastric cancer previously treated with 5-fluorouracil and platinum.
    Japanese journal of clinical oncology, 2005, Volume: 35, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Drug Administration Schedule; Endpoint Determination; Female; Fluorouracil; Humans; Male; Middle Aged; Nervous System Diseases; Neutropenia; Paclitaxel; Platinum; Stomach Neoplasms

2005
Distribution of platinum in the female genital tract and efficacy of radiotherapy combined with transcatheter arterial infusion of cisplatin for locally advanced stage IIIb carcinoma of the uterine cervix.
    Oncology reports, 2009, Volume: 21, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Combined Modality Therapy; Female; Genitalia, Female; Humans; Infusions, Intra-Arterial; Kaplan-Meier Estimate; Lymph Nodes; Middle Aged; Neoplasm Staging; Platinum; Radiotherapy; Uterine Cervical Neoplasms

2009
Pegylated liposomal Doxorubicin and Carboplatin compared with Paclitaxel and Carboplatin for patients with platinum-sensitive ovarian cancer in late relapse.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Jul-10, Volume: 28, Issue:20

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Platinum; Polyethylene Glycols; Recurrence

2010
Cost-effectiveness of combination versus sequential docetaxel and carboplatin for the treatment of platinum-sensitive, recurrent ovarian cancer.
    Cancer, 2012, Jan-15, Volume: 118, Issue:2

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cost-Benefit Analysis; Disease-Free Survival; Docetaxel; Female; Humans; Ovarian Neoplasms; Paclitaxel; Platinum; Quality of Life; Recurrence; Taxoids

2012
A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer.
    Cancer, 2012, Jul-01, Volume: 118, Issue:13

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Humans; Middle Aged; Ovarian Neoplasms; Platinum; Quality of Life; Recurrence; Taxoids

2012
Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients.
    British journal of cancer, 2012, Aug-07, Volume: 107, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Doxorubicin; Female; Humans; Middle Aged; Paclitaxel; Platinum; Polyethylene Glycols; Recurrence; Treatment Outcome

2012
Phase I clinical trial of the novel platin complex dicycloplatin: clinical and pharmacokinetic results.
    International journal of clinical pharmacology and therapeutics, 2013, Volume: 51, Issue:2

    Topics: Adult; Aged; Anemia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; China; Cyclobutanes; Dicarboxylic Acids; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Neoplasms; Neutropenia; Platinum; Thrombocytopenia; Vomiting

2013
Role of ERCC5 promoter polymorphisms in response to platinum-based chemotherapy in patients with advanced non-small-cell lung cancer.
    Anti-cancer drugs, 2013, Volume: 24, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Confidence Intervals; DNA-Binding Proteins; Endonucleases; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nuclear Proteins; Platinum; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Transcription Factors; Transcription Initiation Site; Treatment Outcome; Young Adult

2013
A pooled analysis of limited-stage small-cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy daily radiotherapy: CALGB 30904.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2013, Volume: 8, Issue:8

    Topics: Adult; Aged; Carboplatin; Chemoradiotherapy; Cranial Irradiation; Disease Progression; Female; Humans; Induction Chemotherapy; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Platinum; Proportional Hazards Models; Radiotherapy Dosage; Small Cell Lung Carcinoma

2013
A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer.
    British journal of cancer, 2014, Apr-15, Volume: 110, Issue:8

    Topics: Adaptor Proteins, Signal Transducing; Aged; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Carboplatin; Decitabine; DNA Methylation; Drug Resistance, Neoplasm; Female; Humans; Middle Aged; MutL Protein Homolog 1; Neoplasm Recurrence, Local; Nuclear Proteins; Ovarian Neoplasms; Platinum

2014
[Efficacies of gefitinib versus paclitaxel/carboplatin for patients with advanced pulmonary adenocarcinoma].
    Zhonghua yi xue za zhi, 2014, Aug-13, Volume: 94, Issue:30

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Asian People; Carboplatin; Disease-Free Survival; Gefitinib; Hospitals, General; Humans; Lung Neoplasms; Paclitaxel; Platinum; Quinazolines; Smoking

2014
Aberrant DNA damage response pathways may predict the outcome of platinum chemotherapy in ovarian cancer.
    PloS one, 2015, Volume: 10, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Apoptosis; Carboplatin; Cell Line, Tumor; Disease-Free Survival; DNA Damage; DNA Repair; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Middle Aged; Ovarian Neoplasms; Platinum; Survival Rate

2015
Phase I trial of volasertib, a Polo-like kinase inhibitor, plus platinum agents in solid tumors: safety, pharmacokinetics and activity.
    Investigational new drugs, 2015, Volume: 33, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Cycle Proteins; Cisplatin; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Platinum; Polo-Like Kinase 1; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Pteridines; Young Adult

2015
Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Treatment and Salvage Chemotherapy in EGFR-Mutated Elderly Pulmonary Adenocarcinoma Patients.
    The oncologist, 2015, Volume: 20, Issue:7

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Cisplatin; ErbB Receptors; Female; Humans; Lung Neoplasms; Male; Mutation; Pemetrexed; Platinum; Protein Kinase Inhibitors; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome

2015
Tumor
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2017, 07-01, Volume: 23, Issue:13

    Topics: Aged; BRCA1 Protein; BRCA2 Protein; Carboplatin; Drug Resistance, Neoplasm; Female; Germ-Line Mutation; Humans; Middle Aged; Mutation; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Platinum; Triple Negative Breast Neoplasms

2017
A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Tre
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2020, Volume: 15, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Double-Blind Method; Etoposide; Humans; Lung Neoplasms; Picornaviridae; Platinum

2020
Efficacy and safety of intravenous administration of high-dose selenium for preventing chemotherapy-induced peripheral neuropathy in platinum-sensitive recurrent ovarian, fallopian or primary peritoneal cancer: study protocol for a phase III, double-blind
    Journal of gynecologic oncology, 2021, Volume: 32, Issue:5

    Topics: Administration, Intravenous; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials, Phase III as Topic; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Peripheral Nervous System Diseases; Pharmaceutical Preparations; Platinum; Quality of Life; Randomized Controlled Trials as Topic; Selenium

2021
A phase II study of anlotinib combined with etoposide and platinum-based regimens in the first-line treatment of extensive-stage small cell lung cancer.
    Thoracic cancer, 2022, Volume: 13, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; China; Etoposide; Humans; Indoles; Lung Neoplasms; Platinum; Prospective Studies; Quinolines; Small Cell Lung Carcinoma

2022
Pharmacological ascorbate improves the response to platinum-based chemotherapy in advanced stage non-small cell lung cancer.
    Redox biology, 2022, Volume: 53

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Humans; Leukocytes, Mononuclear; Lung Neoplasms; Paclitaxel; Platinum

2022
Survival after neoadjuvant/induction combination immunotherapy vs combination platinum-based chemotherapy for locally advanced (Stage III) urothelial cancer.
    International journal of cancer, 2022, Dec-01, Volume: 151, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Ipilimumab; Neoadjuvant Therapy; Nivolumab; Platinum; Urinary Bladder Neoplasms

2022
A prospective trial to evaluate the clinical efficacy and safety of neoadjuvant chemotherapy with arsenic trioxide and carboplatin in locally advanced cervical cancer: a study protocol for randomized controlled clinical.
    Trials, 2022, Jul-08, Volume: 23, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Carboplatin; Chemotherapy, Adjuvant; Female; Humans; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Platinum; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome; Uterine Cervical Neoplasms

2022
Phase I trial of ribociclib with platinum chemotherapy in ovarian cancer.
    JCI insight, 2022, 09-22, Volume: 7, Issue:18

    Topics: Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Purines

2022
Results from the IMpower132 China cohort: Atezolizumab plus platinum-based chemotherapy in advanced non-small cell lung cancer.
    Cancer medicine, 2023, Volume: 12, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease-Free Survival; Humans; Lung Neoplasms; Pemetrexed; Platinum

2023
Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trial.
    ESMO open, 2022, Volume: 7, Issue:5

    Topics: Bevacizumab; Carboplatin; Female; Homologous Recombination; Humans; Mangifera; Ovarian Neoplasms; Paclitaxel; Platinum; Poly(ADP-ribose) Polymerases

2022
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 month
    British journal of cancer, 2023, Volume: 128, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Ovarian Epithelial; Doxorubicin; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Platinum; Polyethylene Glycols; Trabectedin

2023
Rationale and Design of the Phase II ANTELOPE Study of Atezolizumab, Carboplatin and nab-Paclitaxel vs. Pembrolizumab, Platinum and Pemetrexed in TTF-1 Negative, Metastatic Lung Adenocarcinoma (AIO-TRK-0122).
    Clinical lung cancer, 2023, Volume: 24, Issue:6

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Pemetrexed; Platinum; Retrospective Studies; Thyroid Nuclear Factor 1

2023
First-line nivolumab, paclitaxel, carboplatin, and bevacizumab for advanced non-squamous non-small cell lung cancer: Updated survival analysis of the ONO-4538-52/TASUKI-52 randomized controlled trial.
    Cancer medicine, 2023, Volume: 12, Issue:16

    Topics: Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Nivolumab; Paclitaxel; Platinum; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Survival Analysis

2023
ONCOS-102 plus pemetrexed and platinum chemotherapy in malignant pleural mesothelioma: a randomized phase 2 study investigating clinical outcomes and the tumor microenvironment.
    Journal for immunotherapy of cancer, 2023, Volume: 11, Issue:9

    Topics: Carboplatin; Cisplatin; Humans; Mesothelioma, Malignant; Pemetrexed; Platinum; Tumor Microenvironment

2023

Other Studies

249 other study(ies) available for platinum and carboplatin

ArticleYear
Meta-analysis of the role of platinum compounds in advanced ovarian carcinoma. The Advanced Ovarian Cancer Trialists Group.
    Seminars in oncology, 1992, Volume: 19, Issue:1 Suppl 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Confidence Intervals; Cyclophosphamide; Doxorubicin; Female; Humans; Meta-Analysis as Topic; Ovarian Neoplasms; Platinum; Randomized Controlled Trials as Topic; Survival Rate

1992
A comparative binding of platinum anti-tumour compounds to plasma proteins in the rat (in vivo) and mouse (in vitro).
    Chemico-biological interactions, 1992, Volume: 85, Issue:2-3

    Topics: Animals; Antineoplastic Agents; Blood Proteins; Carboplatin; Cisplatin; Male; Mice; Mice, Inbred Strains; Organoplatinum Compounds; Platinum; Protein Binding; Radioisotopes; Rats; Rats, Wistar; Sensitivity and Specificity; Structure-Activity Relationship

1992
Comparative study of cisplatin and carboplatin on pharmacokinetics, nephrotoxicity and effect on renal nuclear DNA synthesis in rats.
    Pharmacology & toxicology, 1992, Volume: 70, Issue:2

    Topics: Animals; Blood Urea Nitrogen; Carboplatin; Cisplatin; Creatinine; DNA; Kidney; Male; Platinum; Rats; Rats, Inbred Strains

1992
The long-term retention of platinum in human tissues following the administration of cisplatin or carboplatin for cancer chemotherapy.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:8-9

    Topics: Adolescent; Adult; Aged; Carboplatin; Carcinoma; Cisplatin; Erythrocytes; Female; Humans; Liver; Male; Middle Aged; Osteosarcoma; Ovarian Neoplasms; Platinum; Teratoma; Testicular Neoplasms; Time Factors

1992
5-Fluorouracil (5-FU) and leucovorin in platinum-refractory advanced stage ovarian carcinoma.
    Gynecologic oncology, 1992, Volume: 46, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Administration Schedule; Drug Resistance; Female; Fluorouracil; Humans; Leucovorin; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Platinum; Remission Induction

1992
The role of platinum uptake and glutathione levels in L1210 cells sensitive and resistant to cisplatin, tetraplatin or carboplatin.
    Neoplasma, 1992, Volume: 39, Issue:3

    Topics: Animals; Antineoplastic Agents; Carboplatin; Cisplatin; Drug Resistance; Glutathione; Leukemia L1210; Mice; Organoplatinum Compounds; Platinum; Sensitivity and Specificity; Tumor Cells, Cultured

1992
Responses to salvage chemotherapy in ovarian cancer: a critical need for precise definitions of the treated population.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1992, Volume: 10, Issue:4

    Topics: Carboplatin; Cisplatin; Drug Resistance; Female; Humans; Ovarian Neoplasms; Platinum; Salvage Therapy

1992
[Pharmakinetics of carboplatin in cancer patients].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1991, Volume: 13, Issue:2

    Topics: Adult; Breast Neoplasms; Carboplatin; Carcinoma, Small Cell; Chromatography, High Pressure Liquid; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Platinum

1991
A rationale for carboplatin treatment and abdominal hyperthermia in cancers restricted to the peritoneal cavity.
    Cancer research, 1992, Mar-01, Volume: 52, Issue:5

    Topics: Adenocarcinoma; Animals; Body Temperature; Carboplatin; Colonic Neoplasms; Combined Modality Therapy; Hyperthermia, Induced; Injections, Intraperitoneal; Injections, Intravenous; Male; Peritoneal Neoplasms; Platinum; Rats; Tissue Distribution

1992
The effect of platinum complexes on human skin cells in vivo and in vitro.
    Skin pharmacology : the official journal of the Skin Pharmacology Society, 1991, Volume: 4, Issue:3

    Topics: Administration, Topical; Animals; Carboplatin; Cells, Cultured; Cisplatin; Epidermal Cells; Fibroblasts; Humans; In Vitro Techniques; Keratinocytes; Mice; Mice, Hairless; Platinum; Skin

1991
Characteristics of five human tumor cell lines and sublines resistant to cis-diamminedichloroplatinum(II).
    International journal of cancer, 1991, Jan-21, Volume: 47, Issue:2

    Topics: Adenocarcinoma; Breast Neoplasms; Carboplatin; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Survival; Cisplatin; DNA; Drug Resistance; Glutathione Transferase; Humans; Lung Neoplasms; Melanoma; Neoplasms; Organoplatinum Compounds; Platinum; Sulfhydryl Compounds; Tumor Cells, Cultured

1991
Prediction of the antitumor activity of new platinum analogs based on their ex vivo pharmacodynamics as determined by bioassay.
    Cancer chemotherapy and pharmacology, 1991, Volume: 27, Issue:4

    Topics: Antineoplastic Agents; Biological Assay; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Humans; Lung Neoplasms; Organoplatinum Compounds; Platinum; Tumor Cells, Cultured

1991
Cellular pharmacokinetics of carboplatin and cisplatin in relation to their cytotoxic action.
    Biochemical pharmacology, 1991, Jul-05, Volume: 42, Issue:2

    Topics: Animals; Carboplatin; Cell Line; Cell Survival; Cisplatin; Colony-Forming Units Assay; DNA; Humans; Platinum; Spectrophotometry, Atomic; Thymidine; Tumor Cells, Cultured

1991
[Evaluation of carboplatin administration into the serous cavity in the treatment of malignant effusion].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:11

    Topics: Aged; Carboplatin; Drug Evaluation; Female; Humans; Injections, Intralesional; Lung Neoplasms; Male; Middle Aged; Platinum; Pleural Effusion, Malignant

1991
Comparative intraperitoneal pharmacokinetics of three platinum analogues.
    Cancer chemotherapy and pharmacology, 1991, Volume: 28, Issue:4

    Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Fallopian Tube Neoplasms; Female; Humans; Infusions, Parenteral; Organoplatinum Compounds; Ovarian Neoplasms; Platinum; Radioisotopes; Time Factors

1991
Iron- and ascorbic acid-induced lipid peroxidation in renal microsomes isolated from rats treated with platinum compounds.
    Cancer chemotherapy and pharmacology, 1991, Volume: 28, Issue:6

    Topics: Animals; Antioxidants; Ascorbic Acid; Carboplatin; Cisplatin; Dose-Response Relationship, Drug; Iron; Kidney; Lipid Peroxidation; Male; Microsomes; Phenylenediamines; Platinum; Rats; Rats, Inbred Strains; Stereoisomerism; Time Factors

1991
Experimental studies on the pharmacokinetics and nephrotoxicity of carboplatin (cis-diammine-1, 1-cyclobutane dicarboxylate platinum II) in rats.
    The Journal of toxicological sciences, 1991, Volume: 16, Issue:3

    Topics: Animals; Carboplatin; Injections, Intravenous; Kidney; Male; Platinum; Rats; Rats, Inbred Strains

1991
Continuous infusion carboplatin on a 21-day schedule: a phase I and pharmacokinetic study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:1

    Topics: Adult; Aged; Carboplatin; DNA, Neoplasm; Drug Administration Schedule; Drug Evaluation; Female; Glomerular Filtration Rate; Humans; Infusions, Intravenous; Kidney; Leukopenia; Male; Middle Aged; Neoplasms; Platinum; Regional Blood Flow; Remission Induction

1991
A study of human small-cell lung carcinoma (hSCLC) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (CDDP) resistance.
    International journal of cancer, 1990, Jul-15, Volume: 46, Issue:1

    Topics: Antibodies, Monoclonal; Antigens, CD; Antigens, Neoplasm; Antineoplastic Agents; Carboplatin; Carcinoma, Small Cell; Cell Line; Cisplatin; Coloring Agents; Drug Resistance; Drug Screening Assays, Antitumor; Glutathione; Humans; Lung Neoplasms; Organoplatinum Compounds; Platinum; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured

1990
Nephrotoxicity of cisplatin, carboplatin and transplatin. A comparative in vitro study.
    Archives of toxicology, 1990, Volume: 64, Issue:5

    Topics: Animals; Carboplatin; Cisplatin; Gluconeogenesis; Glucose-6-Phosphatase; In Vitro Techniques; Kidney Diseases; Male; Malondialdehyde; Microsomes; Organoplatinum Compounds; p-Aminohippuric Acid; Platinum; Rabbits; Rats; Rats, Inbred Strains; Species Specificity; Tetraethylammonium Compounds

1990
Evaluation of platinum-DNA adduct levels relative to known prognostic variables in a cohort of ovarian cancer patients.
    Cancer research, 1990, Apr-15, Volume: 50, Issue:8

    Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Cohort Studies; DNA; Female; Humans; Leukocytes; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Platinum; Prognosis

1990
The effects of the platinum anti-tumour agents on renal cell kinetics and the response to a second cytotoxic agent.
    Cell and tissue kinetics, 1990, Volume: 23, Issue:2

    Topics: Animals; Antineoplastic Agents; Carboplatin; Cell Division; Cell Survival; Cisplatin; Cytotoxins; Epithelial Cells; Epithelium; Kidney; Mice; Organoplatinum Compounds; Platinum; Uranyl Nitrate

1990
The tissue distribution in rats of [195mPt]carboplatin following intravenous, intraperitoneal and oral administration.
    International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology, 1990, Volume: 17, Issue:4

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Carboplatin; Injections, Intraperitoneal; Injections, Intravenous; Male; Organoplatinum Compounds; Platinum; Radioisotopes; Rats; Rats, Inbred Strains; Tissue Distribution

1990
Kinetics and mechanism of uptake of platinum-based pharmaceuticals by the rat small intestine.
    Biochemical pharmacology, 1990, Sep-15, Volume: 40, Issue:6

    Topics: Animals; Antineoplastic Agents; Carboplatin; Cisplatin; Cyanides; Half-Life; Intestinal Absorption; Intestine, Small; Male; Nitrogen; Organoplatinum Compounds; Platinum; Rats; Rats, Inbred Strains

1990
In vivo toxicity of cisplatin and carboplatin on the Leydig cell function and effect of the human choriogonadotropin.
    Biochemical pharmacology, 1989, Feb-15, Volume: 38, Issue:4

    Topics: Animals; Carboplatin; Chorionic Gonadotropin; Cisplatin; Cytochrome P-450 Enzyme System; Leydig Cells; Male; Microsomes; Organoplatinum Compounds; Platinum; Rats; Rats, Inbred Strains; Testosterone

1989
Effect of heat on the cytotoxicity and interaction with DNA of a series of platinum complexes.
    International journal of radiation oncology, biology, physics, 1989, Volume: 16, Issue:2

    Topics: Animals; Antineoplastic Agents; Carboplatin; Cell Survival; Chlorides; DNA, Superhelical; Hot Temperature; Mice; Organoplatinum Compounds; Platinum; Platinum Compounds

1989
[Pharmacokinetics of new cisplatin analogues in experimental animals].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:4 Pt 2-2

    Topics: Animals; Antineoplastic Agents; Carboplatin; Cisplatin; Mice; Organoplatinum Compounds; Platinum; Protein Binding; Rabbits; Sarcoma 180; Tissue Distribution

1989
[Present status of cisplatin (CDDP) analogues in Japan].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:4 Pt 2-2

    Topics: Antineoplastic Agents; Carboplatin; Chemical Phenomena; Chemistry; Cisplatin; Female; Humans; Kidney; Leukopenia; Nervous System; Organoplatinum Compounds; Platinum; Protein Binding; Thrombocytopenia

1989
Pharmacokinetics of platinum in cancer patients treated with carboplatin in combination with high-dose methotrexate.
    Pharmaceutical research, 1989, Volume: 6, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Creatinine; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasms; Organoplatinum Compounds; Platinum; Spectrophotometry, Atomic; Ultrafiltration

1989
An autoradiographic study of the intrarenal localisation and retention of cisplatin, iproplatin and paraplatin.
    Cancer chemotherapy and pharmacology, 1988, Volume: 22, Issue:3

    Topics: Animals; Antineoplastic Agents; Autoradiography; Carboplatin; Cisplatin; Isotope Labeling; Kidney; Male; Mice; Organoplatinum Compounds; Platinum; Quality Control; Radioisotopes

1988
The disposition of carboplatin in ovarian cancer patients.
    Cancer chemotherapy and pharmacology, 1988, Volume: 22, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Chromatography, High Pressure Liquid; Female; Humans; Infusions, Intravenous; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Platinum; Protein Binding

1988
Pharmacokinetics of carboplatin after intraperitoneal administration.
    Cancer chemotherapy and pharmacology, 1988, Volume: 21, Issue:1

    Topics: Aged; Antineoplastic Agents; Carboplatin; Female; Humans; Injections, Intraperitoneal; Middle Aged; Organoplatinum Compounds; Peritoneal Cavity; Platinum

1988
Platinum levels in murine tumor following intraperitoneal administration of cisplatin or paraplatin.
    NCI monographs : a publication of the National Cancer Institute, 1988, Issue:6

    Topics: Animals; Carboplatin; Cisplatin; Combined Modality Therapy; Female; Injections, Intraperitoneal; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Organoplatinum Compounds; Platinum

1988
Clinical pharmacokinetics of carboplatin.
    Journal of clinical pharmacology, 1988, Volume: 28, Issue:3

    Topics: Antineoplastic Agents; Carboplatin; Chromatography, High Pressure Liquid; Cisplatin; DNA; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Organoplatinum Compounds; Platinum; Protein Binding; Spectrophotometry, Atomic

1988
[Pharmacokinetics of carboplatin (CBDCA) and tissue concentration of platinum in gynecologic organs].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:6

    Topics: Antineoplastic Agents; Blood Platelets; Blood Urea Nitrogen; Carboplatin; Cervix Uteri; Erythrocytes; Female; Genital Neoplasms, Female; Humans; Infusions, Intravenous; Organoplatinum Compounds; Ovary; Platinum; Uterus

1988
The comparative tissues distribution of platinum and 14C in mice receiving 14C-labelled carboplatin.
    Cancer chemotherapy and pharmacology, 1988, Volume: 22, Issue:1

    Topics: Animals; Biotransformation; Carbon Radioisotopes; Carboplatin; Ileum; Kidney; Liver; Mice; Mice, Inbred BALB C; Muscles; Organoplatinum Compounds; Platinum; Tissue Distribution

1988
Plasma free platinum pharmacokinetics in patients treated with high dose carboplatin.
    European journal of cancer & clinical oncology, 1987, Volume: 23, Issue:9

    Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Female; Glomerular Filtration Rate; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Platinum

1987
Pharmacokinetics of carboplatin after i.v. administration.
    Cancer treatment reports, 1987, Volume: 71, Issue:12

    Topics: Carboplatin; Carcinoma; Female; Humans; Injections, Intravenous; Organoplatinum Compounds; Ovarian Neoplasms; Platinum

1987
Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.
    Cancer research, 1986, Volume: 46, Issue:4 Pt 2

    Topics: Animals; Antineoplastic Agents; Carboplatin; Carcinoma 256, Walker; Cell Survival; Cells, Cultured; Cisplatin; DNA; Humans; Kinetics; Nucleic Acid Conformation; Organoplatinum Compounds; Plasmids; Platinum

1986
Uptake of platinum compounds in human tumors. In vitro study.
    Bulletin du cancer, 1986, Volume: 73, Issue:5

    Topics: Aged; Antineoplastic Agents; Carboplatin; Cells, Cultured; Cisplatin; Dose-Response Relationship, Drug; Humans; Laryngeal Neoplasms; Male; Middle Aged; Mouth Neoplasms; Organoplatinum Compounds; Pharyngeal Neoplasms; Platinum; Time Factors

1986
Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II).
    Cancer research, 1987, Jan-15, Volume: 47, Issue:2

    Topics: Biological Transport; Cadmium; Carboplatin; Carcinoma, Squamous Cell; Cell Line; Cell Membrane; Cisplatin; Drug Resistance; Glutathione Transferase; Humans; Metallothionein; Organoplatinum Compounds; Platinum; Structure-Activity Relationship; Sulfhydryl Compounds

1987
Microscale syntheses of anti-tumour platinum compounds labelled with 191Pt.
    The International journal of applied radiation and isotopes, 1985, Volume: 36, Issue:3

    Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Isotope Labeling; Organoplatinum Compounds; Platinum; Radioisotopes

1985
Phase I study and pharmacokinetics of intraperitoneal carboplatin.
    Cancer treatment reviews, 1985, Volume: 12 Suppl A

    Topics: Antineoplastic Agents; Carboplatin; Drug Evaluation; Humans; Kinetics; Neoplasms; Organoplatinum Compounds; Platinum

1985
[Development of antitumor platinum complexes].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1983, Volume: 10, Issue:12

    Topics: Animals; Antineoplastic Agents; Carboplatin; Cisplatin; Cyclohexylamines; Humans; Kidney; Neoplasms; Neoplasms, Experimental; Organoplatinum Compounds; Platinum; Structure-Activity Relationship

1983
Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function.
    Cancer research, 1984, Volume: 44, Issue:4

    Topics: Antineoplastic Agents; Carboplatin; Drug Evaluation; Humans; Kidney; Kinetics; Neoplasms; Organoplatinum Compounds; Platinum

1984
Phase I clinical and pharmacologic trial of carboplatin daily for 5 days.
    Cancer treatment reports, 1984, Volume: 68, Issue:9

    Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Drug Evaluation; Female; Humans; Kinetics; Male; Middle Aged; Neoplasms; Organoplatinum Compounds; Platinum; Pleural Effusion; Thrombocytopenia

1984
In vivo and in vitro effectivity of some platinum complexes.
    Neoplasma, 1984, Volume: 31, Issue:6

    Topics: Animals; Antineoplastic Agents; Carboplatin; Cell Line; Cisplatin; Drug Evaluation, Preclinical; Female; Injections, Intraperitoneal; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Male; Mice; Mice, Inbred DBA; Organoplatinum Compounds; Platinum

1984
Binding characteristics of (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-2-platin um(II) to DNA, RNA and protein molecules in HeLa cells and its lethal effect: comparison with cis- and trans-diamminedichloroplatinums(II).
    Japanese journal of cancer research : Gann, 1994, Volume: 85, Issue:1

    Topics: Carboplatin; Cell Division; Cell Survival; Cisplatin; DNA; HeLa Cells; Humans; Platinum; Proteins; RNA

1994
Platinum-DNA adducts assayed in leukocytes of patients with germ cell tumors measured by atomic absorbance spectrometry and enzyme-linked immunosorbent assay.
    Cancer, 1994, Jun-01, Volume: 73, Issue:11

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Cyclophosphamide; Dactinomycin; DNA; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Germinoma; Humans; Leukocytes; Male; Middle Aged; Ovarian Neoplasms; Platinum; Spectrophotometry, Atomic; Testicular Neoplasms; Vinblastine

1994
Platinum concentrations in uterus and serum after internal iliac arterial infusion of platinum compounds in rabbits.
    Obstetrics and gynecology, 1995, Volume: 86, Issue:2

    Topics: Animals; Antineoplastic Agents; Carboplatin; Cisplatin; Female; Iliac Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Jugular Veins; Organoplatinum Compounds; Platinum; Rabbits; Uterus

1995
[The study of platinum concentration in retroperitoneal lymph nodes after intraperitoneal carboplatin in ovarian tumors].
    Zhonghua fu chan ke za zhi, 1995, Volume: 30, Issue:5

    Topics: Adult; Aged; Carboplatin; Carcinoma; Cystadenocarcinoma, Mucinous; Female; Humans; Infusions, Parenteral; Lymph Nodes; Middle Aged; Ovarian Neoplasms; Platinum; Retroperitoneal Space

1995
Carboplatin enhances the production and persistence of radiation-induced DNA single-strand breaks.
    Radiation research, 1995, Volume: 143, Issue:3

    Topics: Animals; Carboplatin; Cells, Cultured; Cricetinae; DNA Adducts; DNA Damage; DNA Repair; DNA, Single-Stranded; Platinum; Radiation Tolerance

1995
Detection of platinum-DNA adducts by 32P-postlabelling.
    Nucleic acids research, 1995, Apr-25, Volume: 23, Issue:8

    Topics: Animals; Carboplatin; Chromatography, Ion Exchange; Cisplatin; DNA; DNA Adducts; Female; Isotope Labeling; Phosphorus Radioisotopes; Platinum; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity

1995
Differential toxicity of cisplatin, carboplatin, and CI-973 correlates with cellular platinum levels in rat renal cortical slices.
    Toxicology and applied pharmacology, 1995, Volume: 132, Issue:2

    Topics: Animals; Antineoplastic Agents; Carboplatin; Cisplatin; In Vitro Techniques; Kidney Cortex; Male; Platinum; Protein Biosynthesis; Proteins; Rats; Rats, Wistar

1995
Effect of ultrafilterable platinum concentration on cisplatin and carboplatin cytotoxicity in human tumor and bone marrow cells in vitro.
    Pharmaceutical research, 1994, Volume: 11, Issue:9

    Topics: Bone Marrow; Carboplatin; Cisplatin; Culture Media; Humans; Platinum; Protein Binding; Tumor Cells, Cultured; Ultrafiltration

1994
Analysis of enloplatin by liquid chromatography and of platinum by atomic absorption spectrometry in various biological fluids.
    Journal of pharmaceutical and biomedical analysis, 1994, Volume: 12, Issue:8

    Topics: Animals; Antineoplastic Agents; Carboplatin; Chromatography, Liquid; Dogs; Freezing; Humans; Indicators and Reagents; Platinum; Quality Control; Rats; Spectrophotometry, Atomic; Ultrafiltration

1994
Potentiation of cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) by amphotericin B in BALB/c nude mice bearing human ovarian carcinoma cells.
    Japanese journal of cancer research : Gann, 1994, Volume: 85, Issue:11

    Topics: Amphotericin B; Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Synergism; Female; Humans; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Ovarian Neoplasms; Platinum

1994
Current sample handling methods for measurement of platinum-DNA adducts in leucocytes in man lead to discrepant results in DNA adduct levels and DNA repair.
    British journal of cancer, 1995, Volume: 71, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Specimen Collection; Carboplatin; Cisplatin; DNA Adducts; DNA Repair; DNA, Neoplasm; Etoposide; Humans; Kinetics; Leukocytes; Neoplasms; Platinum

1995
Comparative pharmacokinetics of oxaliplatin (L-OHP) and carboplatin (CBDCA) in mice with reference to circadian dosing time.
    Biopharmaceutics & drug disposition, 1994, Volume: 15, Issue:9

    Topics: Animals; Antineoplastic Agents; Carboplatin; Circadian Rhythm; Erythrocytes; Male; Mice; Mice, Inbred Strains; Organoplatinum Compounds; Oxaliplatin; Plasma; Platinum; Protein Binding

1994
Potentiation by interleukin 1 alpha of cisplatin and carboplatin antitumor activity: schedule-dependent and pharmacokinetic effects in the RIF-1 tumor model.
    Cancer research, 1994, Oct-15, Volume: 54, Issue:20

    Topics: Animals; Carboplatin; Cell Division; Cisplatin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Female; Fibrosarcoma; Interleukin-1; Mice; Mice, Inbred C3H; Platinum; Receptors, Interleukin-1; Time Factors; Tumor Cells, Cultured

1994
Therapeutic dilemma of disseminated CNS germinoma and the potential of increased platinum-based chemotherapy delivery with osmotic blood-brain barrier disruption.
    Pediatric neurosurgery, 1994, Volume: 21, Issue:1

    Topics: Adolescent; Adult; Blood-Brain Barrier; Brain; Brain Neoplasms; Carboplatin; Cisplatin; Etoposide; Female; Germinoma; Hearing Loss, High-Frequency; Humans; Magnetic Resonance Imaging; Male; Mannitol; Platinum; Treatment Outcome

1994
Cerebral metastases from epithelial ovarian carcinoma treated with carboplatin.
    Gynecologic oncology, 1994, Volume: 55, Issue:2

    Topics: Adenocarcinoma, Papillary; Adult; Aged; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Female; Humans; Middle Aged; Ovarian Neoplasms; Platinum

1994
[A study of intra-arterial infusion with carboplatin (CBDCA) for 2 patients with maxillary gingival cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:7

    Topics: Aged; Carboplatin; Carcinoma, Squamous Cell; Female; Gingival Neoplasms; Humans; Infusions, Intra-Arterial; Male; Maxilla; Platinum

1994
[Distribution of platinum in the female genital tract after intraarterial carboplatin infusion during the operation of uterine cervical cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:12

    Topics: Adenocarcinoma; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Genitalia, Female; Humans; Infusions, Intra-Arterial; Intraoperative Care; Lymph Nodes; Platinum; Uterine Cervical Neoplasms

1994
A comparison of in vitro platinum-DNA adduct formation between carboplatin and cisplatin.
    The International journal of biochemistry, 1994, Volume: 26, Issue:8

    Topics: Base Composition; Base Sequence; Binding Sites; Carboplatin; Chromatography, High Pressure Liquid; Cisplatin; DNA; DNA Damage; Electrophoresis, Agar Gel; Hydrogen-Ion Concentration; Kinetics; Molecular Sequence Data; Nucleic Acid Conformation; Plasmids; Platinum

1994
Initial measurements of platinum concentration in head and neck tumors using X-ray fluorescence.
    Basic life sciences, 1993, Volume: 60

    Topics: Body Composition; Carboplatin; Cisplatin; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Platinum; Spectrometry, X-Ray Emission; Technetium

1993
[Pharmacokinetics of carboplatin in a patient under hemodialysis].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:4

    Topics: Carboplatin; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Middle Aged; Ovarian Neoplasms; Platinum; Renal Dialysis

1994
Effects of temperature on the interaction of cisplatin and carboplatin with cellular DNA.
    Biochemical pharmacology, 1993, Oct-05, Volume: 46, Issue:7

    Topics: Animals; Carboplatin; Cell Survival; Cisplatin; DNA; DNA Adducts; Dose-Response Relationship, Drug; Hot Temperature; Platinum; Rats; Tumor Cells, Cultured

1993
Enhanced formation of reactive species from cis-diammine-(1,1-cyclobutanedicarboxylato)-platinum(II) (carboplatin) in the presence of oxygen free radicals.
    Biochemical pharmacology, 1993, Oct-19, Volume: 46, Issue:8

    Topics: Animals; Ascorbic Acid; Carboplatin; Cisplatin; DNA; Drug Stability; Edetic Acid; Ferrous Compounds; Free Radicals; Oxygen; Platinum

1993
Drug-induced DNA modification in buccal cells of cancer patients receiving carboplatin and cisplatin combination chemotherapy, as determined by an immunocytochemical method: interindividual variation and correlation with disease response.
    Cancer research, 1993, Dec-01, Volume: 53, Issue:23

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; DNA; Dose-Response Relationship, Drug; Female; Humans; Immunohistochemistry; Male; Middle Aged; Mouth Mucosa; Neoplasms; Pilot Projects; Platinum

1993
Massive cisplatin overdose by accidental substitution for carboplatin. Toxicity and management.
    Cancer, 1993, Dec-15, Volume: 72, Issue:12

    Topics: Aged; Carboplatin; Cisplatin; DNA Repair; DNA-Binding Proteins; Drug Overdose; Female; Humans; Plasmapheresis; Platinum

1993
Sequence dependence of the hyperthermic potentiation of carboplatin-induced cytotoxicity and intracellular platinum accumulation in HeLa cells.
    British journal of cancer, 1993, Volume: 68, Issue:2

    Topics: Biological Transport; Carboplatin; Cell Survival; Dose-Response Relationship, Drug; HeLa Cells; Hot Temperature; Humans; Kinetics; Platinum; Time Factors

1993
Comparison of carboplatin pharmacokinetics between an anephric child and two children with normal renal function.
    Medical and pediatric oncology, 1993, Volume: 21, Issue:5

    Topics: Blood Proteins; Brain Neoplasms; Carboplatin; Child, Preschool; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Kidney; Nephrectomy; Platinum; Protein Binding; Renal Dialysis; Ultrafiltration; Wilms Tumor

1993
Platinum complex-induced dysfunction of cultured renal proximal tubule cells. A comparative study of carboplatin and transplatin with cisplatin.
    Archives of toxicology, 1993, Volume: 67, Issue:5

    Topics: Animals; Carboplatin; Cell Survival; Cells, Cultured; Cisplatin; DNA; Enzymes; Glucose; Glutathione; Kidney Tubules, Proximal; Microvilli; Opossums; Organoplatinum Compounds; Platinum; Protein Biosynthesis; Rabbits; Sodium-Potassium-Exchanging ATPase; Succinate Dehydrogenase

1993
Effect of tumor presence on cisplatin and carboplatin: disposition in the isolated, perfused tumor and skin flap.
    Cancer chemotherapy and pharmacology, 1993, Volume: 32, Issue:1

    Topics: Animals; Carboplatin; Chemotherapy, Cancer, Regional Perfusion; Choriocarcinoma; Cisplatin; Humans; Models, Biological; Platinum; Skin; Swine; Tumor Cells, Cultured; Vascular Resistance

1993
A single-sample assay for the estimation of the area under the free carboplatin plasma concentration versus time curve.
    Cancer chemotherapy and pharmacology, 1996, Volume: 37, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Carboplatin; Female; Humans; Linear Models; Male; Middle Aged; Ovarian Neoplasms; Platinum; Prospective Studies; Protein Binding; Regression Analysis; Reproducibility of Results; Retrospective Studies

1996
Comparison of ethanol plasma-protein precipitation with plasma ultrafiltration and trichloroacetic acid protein precipitation for the measurement of unbound platinum concentrations.
    Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:4

    Topics: Blood Proteins; Carboplatin; Chemical Precipitation; Cisplatin; Ethanol; Humans; Platinum; Spectrophotometry, Atomic; Trichloroacetic Acid; Ultrafiltration

1996
Abdomino-pelvic hyperthermia and intraperitoneal carboplatin in epithelial ovarian cancer: feasibility, tolerance and pharmacology.
    International journal of radiation oncology, biology, physics, 1996, Jul-15, Volume: 35, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Cohort Studies; Combined Modality Therapy; Feasibility Studies; Female; Humans; Hyperthermia, Induced; Injections, Intraperitoneal; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Platinum; Treatment Outcome

1996
[Intraperitoneal administration of carboplatin loaded alpha-tricalcium phosphate (alpha-TCP) particles in rats bearing abdominal carcinomatosis].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:11

    Topics: Animals; Antineoplastic Agents; Ascites; Biodegradation, Environmental; Calcium Phosphates; Carboplatin; Disease Models, Animal; Drug Carriers; Infusions, Parenteral; Male; Peritoneal Neoplasms; Platinum; Rats

1996
Concurrent daily carboplatin and accelerated hyperfractionated thoracic radiotherapy in locally advanced nonsmall cell lung cancer.
    International journal of radiation oncology, biology, physics, 1997, Jan-01, Volume: 37, Issue:1

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Administration Schedule; Esophagitis; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Platinum; Radiotherapy Dosage; Survival Analysis

1997
Inhibitory effects of platinum anticancer agents on rat brain protein kinase C.
    Biochemical Society transactions, 1997, Volume: 25, Issue:1

    Topics: Animals; Antineoplastic Agents; Brain; Carboplatin; Cisplatin; Enzyme Inhibitors; Male; Organoplatinum Compounds; Platinum; Protein Kinase C; Rats; Rats, Wistar

1997
Influence of single and multiple doses of amifostine on the efficacy and the pharmacokinetics of carboplatin in mice.
    British journal of cancer, 1997, Volume: 75, Issue:10

    Topics: Amifostine; Animals; Antineoplastic Agents; Body Temperature; Carboplatin; DNA Adducts; Drug Administration Schedule; Drug Synergism; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Platinum; Radiation-Protective Agents; Transplantation, Heterologous

1997
A Bayesian dosing method for carboplatin given by continuous infusion for 120 h.
    Cancer chemotherapy and pharmacology, 1997, Volume: 40, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Carboplatin; Drug Administration Schedule; Drug Tolerance; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Neoplasms; Platinum

1997
Determination of the target volume of HeLa cells treated with platinum-195 m radiolabeled cis-diammine(1, 1-cyclobutane-dicarboxylato)-platinum(II); comparison with cis- and trans-diamminedichloroplatinums(II).
    Nuclear medicine and biology, 1994, Volume: 21, Issue:7

    Topics: Antineoplastic Agents; Carboplatin; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; HeLa Cells; Humans; Isotopes; Platinum

1994
Internal iliac arterial infusion chemotherapy for rabbit invasive bladder cancer.
    International journal of urology : official journal of the Japanese Urological Association, 1997, Volume: 4, Issue:5

    Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Doxorubicin; Iliac Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Lung Neoplasms; Male; Neoplasm Invasiveness; Platinum; Rabbits; Urinary Bladder Neoplasms

1997
Second-line therapy with paclitaxel and carboplatin for recurrent disease following first-line therapy with paclitaxel and platinum in ovarian or peritoneal carcinoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carboplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Platinum; Treatment Outcome

1998
Monitoring local disposition kinetics of carboplatin in vivo after subcutaneous injection in rats by means of 195Pt NMR.
    Journal of magnetic resonance (San Diego, Calif. : 1997), 1998, Volume: 133, Issue:1

    Topics: Animals; Antineoplastic Agents; Carboplatin; Chlorides; Cisplatin; Dimethyl Sulfoxide; Dimethylformamide; Electron Spin Resonance Spectroscopy; Injections, Subcutaneous; Magnetic Resonance Spectroscopy; Male; Neck; Platinum; Platinum Compounds; Rats; Rats, Wistar; Signal Processing, Computer-Assisted; Skin; Solvents; Water

1998
Quantitative imaging microscopy for the sensitive detection of administered metal containing drugs in single cells and tissue slices--a demonstration using platinum based chemotherapeutic agent.
    Journal of pharmaceutical and biomedical analysis, 1998, Volume: 17, Issue:4-5

    Topics: Animals; Antineoplastic Agents; Carboplatin; CHO Cells; Cisplatin; Cricetinae; Kidney Tubules; Male; Platinum; Rats; Rats, Inbred F344; Sensitivity and Specificity; Spectrometry, X-Ray Emission

1998
Stability and cellular studies of [rac-1,2-bis(4-fluorophenyl)-ethylenediamine][cyclobutane-1,1- dicarboxylato]platinum(II), a novel, highly active carboplatin derivative.
    Journal of cancer research and clinical oncology, 1998, Volume: 124, Issue:11

    Topics: Breast Neoplasms; Carboplatin; Cell Size; Chromatography, High Pressure Liquid; Drug Screening Assays, Antitumor; Drug Stability; Female; Humans; Magnetic Resonance Spectroscopy; Ovarian Neoplasms; Platinum; Serum Albumin; Solubility; Tumor Cells, Cultured

1998
European hospitals as a source for platinum in the environment in comparison with other sources.
    The Science of the total environment, 1999, Jan-12, Volume: 225, Issue:1-2

    Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Environmental Pollution; Europe; Hospitals; Humans; Medical Waste; Platinum; Sewage; Vehicle Emissions; Water Pollution, Chemical

1999
1Alpha,25dihydroxyvitamin D3 and platinum drugs act synergistically to inhibit the growth of prostate cancer cell lines.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:3

    Topics: Anticarcinogenic Agents; Antineoplastic Agents; Calcitriol; Carboplatin; Cell Cycle; Cell Division; Cholecalciferol; Cisplatin; Dose-Response Relationship, Drug; Drug Synergism; Humans; Male; Platinum; Prostatic Neoplasms; Tumor Cells, Cultured

1999
Determination of platinum (II,IV) and palladium(II) as thiocyanate complexes by capillary zone electrophoresis analysis of carboplatin and similar drugs.
    Journal of chromatography. A, 1999, Feb-26, Volume: 834, Issue:1-2

    Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Electrophoresis, Capillary; Palladium; Platinum; Spectrophotometry; Thiocyanates; Vehicle Emissions

1999
Determination of platinum complexes in clinical samples by a rapid flameless atomic absorption spectrometry assay.
    Therapeutic drug monitoring, 1999, Volume: 21, Issue:6

    Topics: Anticoagulants; Antineoplastic Agents; Blood Specimen Collection; Calibration; Carboplatin; Drug Stability; Edetic Acid; Heparin; Humans; Platinum; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Atomic; Temperature; Time Factors; Ultrafiltration

1999
In vivo measurement of platinum in the kidneys using X-ray fluorescence.
    Annals of the New York Academy of Sciences, 2000, Volume: 904

    Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Humans; Kidney; Neoplasms; Organoplatinum Compounds; Photons; Platinum; Scattering, Radiation; Sensitivity and Specificity; Spectrometry, X-Ray Emission

2000
Intravenous cereport (RMP-7) modifies topographic uptake profile of carboplatin within rat glioma and brain surrounding tumor, elevates platinum levels, and enhances survival.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 293, Issue:3

    Topics: Animals; Antineoplastic Agents; Bradykinin; Brain Neoplasms; Carboplatin; Glioma; Infusions, Intravenous; Male; Paclitaxel; Platinum; Rats; Rats, Inbred F344

2000
Intraperitoneal chemotherapy and intraperitoneal washing cytology in management of ovarian cancer.
    Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27 Suppl 2

    Topics: Antineoplastic Agents; Carboplatin; Female; Humans; Infusions, Parenteral; Neoplasm, Residual; Ovarian Neoplasms; Peritoneal Lavage; Platinum; Reoperation; Survival Analysis

2000
Chemotherapy for malignant mixed Müllerian tumors of the ovary.
    Gynecologic oncology, 2000, Volume: 79, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Female; Humans; Ifosfamide; Middle Aged; Mixed Tumor, Mullerian; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Platinum; Retrospective Studies; Survival Analysis; Taxoids; Treatment Outcome

2000
The platelet-sparing effect of paclitaxel is not related to changes in the pharmacokinetics of carboplatin.
    Cancer chemotherapy and pharmacology, 2001, Volume: 47, Issue:1

    Topics: Age Factors; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Body Surface Area; Carboplatin; Cyclophosphamide; Female; Humans; Injections, Intraperitoneal; Middle Aged; Ovarian Neoplasms; Paclitaxel; Platelet Count; Platinum; Prospective Studies; Thrombocytopenia

2001
Synthesis, characterization and antitumor activity of quinolone-platinum(II) conjugates.
    Journal of inorganic biochemistry, 2001, Dec-01, Volume: 87, Issue:3

    Topics: Animals; Antineoplastic Agents; Carboplatin; Fluoroquinolones; Leukemia L1210; Magnetic Resonance Spectroscopy; Models, Chemical; Molecular Structure; Nalidixic Acid; Oxolinic Acid; Platinum; Quinolizines; Quinolones; Spectrophotometry, Infrared; Tumor Cells, Cultured

2001
Retrospective analysis of carboplatin and paclitaxel as initial second-line therapy for recurrent epithelial ovarian carcinoma: application toward a dynamic disease state model of ovarian cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Mar-01, Volume: 20, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Female; Follow-Up Studies; Humans; Middle Aged; Models, Theoretical; Ovarian Neoplasms; Paclitaxel; Platinum; Retrospective Studies; Survival Rate; Treatment Outcome

2002
Topotecan as first-line therapy for small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 2003, Volume: 41 Suppl 4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell; Cisplatin; Etoposide; Forecasting; Humans; Lung Neoplasms; Paclitaxel; Platinum; Topotecan

2003
Kinetic study on the reactions of platinum drugs with glutathione.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 308, Issue:2

    Topics: Antineoplastic Agents; Carboplatin; Chromatography, High Pressure Liquid; Cisplatin; Glutathione; Kinetics; Organoplatinum Compounds; Oxaliplatin; Platinum; Spectrophotometry, Ultraviolet

2004
Toxicity and cerebrospinal fluid levels of carboplatin chronically infused into the brainstem of a primate.
    Journal of neuro-oncology, 2004, Volume: 67, Issue:3

    Topics: Animals; Antineoplastic Agents; Brain Stem; Carboplatin; Infusion Pumps; Injections, Intraperitoneal; Macaca fascicularis; Male; Platinum; Pons

2004
Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B.
    Molecular pharmacology, 2004, Volume: 66, Issue:1

    Topics: Adenosine Triphosphatases; Antineoplastic Agents; Carboplatin; Cation Transport Proteins; Cell Division; Cisplatin; Copper; Copper-Transporting ATPases; DNA; Fibroblasts; Humans; Microscopy; Organoplatinum Compounds; Oxaliplatin; Platinum; Recombinant Fusion Proteins; Transfection

2004
Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Jul-15, Volume: 10, Issue:14

    Topics: Adenosine Triphosphatases; Antineoplastic Agents; Biological Transport; Carboplatin; Cation Transport Proteins; Cell Line, Tumor; Cisplatin; Copper; Copper-Transporting ATPases; DNA Adducts; Drug Resistance, Neoplasm; Female; Humans; Kinetics; Microscopy, Confocal; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Platinum; Recombinant Fusion Proteins; Time Factors

2004
Cisplatin stabilizes a multimeric complex of the human Ctr1 copper transporter: requirement for the extracellular methionine-rich clusters.
    The Journal of biological chemistry, 2004, Nov-05, Volume: 279, Issue:45

    Topics: Amino Acid Motifs; Antineoplastic Agents; Blotting, Western; Carboplatin; Cation Transport Proteins; Cell Line; Chelating Agents; Cisplatin; Copper; Copper Transporter 1; Cycloheximide; Dimerization; Dimethyldithiocarbamate; DNA, Complementary; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Endocytosis; Humans; Immunoblotting; Methionine; Microscopy, Fluorescence; Models, Biological; Mutagenesis; Organoplatinum Compounds; Oxaliplatin; Platinum; Protein Binding; Protein Structure, Tertiary; Protein Synthesis Inhibitors; Time Factors; Transfection

2004
Effect of glomerular filtration rate on clearance and myelotoxicity of carboplatin in cats with tumors.
    American journal of veterinary research, 2004, Volume: 65, Issue:11

    Topics: Animals; Area Under Curve; Blood Cell Count; Blood Platelets; Carboplatin; Cat Diseases; Cats; Dose-Response Relationship, Drug; Glomerular Filtration Rate; Neoplasms; Neutrophils; Platinum; Regression Analysis; Spectrophotometry, Atomic; Technetium Tc 99m Pentetate

2004
[Comparison of pelvic transarterial chemoembolization with lipiodol ultra-fluid carboplatin and transarterial carboplatin through experiment in dogs].
    Ai zheng = Aizheng = Chinese journal of cancer, 2004, Volume: 23, Issue:11 Suppl

    Topics: Animals; Antineoplastic Agents; Area Under Curve; Carboplatin; Chemoembolization, Therapeutic; Dogs; Female; Iliac Artery; Infusions, Intra-Arterial; Iodized Oil; Platinum; Random Allocation; Uterus

2004
Anticancer activity of a series of platinum complexes integrating demethylcantharidin with isomers of 1,2-diaminocyclohexane.
    Bioorganic & medicinal chemistry letters, 2006, Mar-15, Volume: 16, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Cantharidin; Carboplatin; Carcinoma, Hepatocellular; Cell Cycle; Cisplatin; Colorectal Neoplasms; Cyclohexylamines; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Isomerism; Liver Neoplasms; Organoplatinum Compounds; Oxaliplatin; Platinum; Tumor Cells, Cultured

2006
High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity.
    Molecular pharmacology, 2006, Volume: 70, Issue:1

    Topics: Animals; Antineoplastic Agents; Carboplatin; Cell Line, Transformed; Cells, Cultured; Cisplatin; DNA Adducts; Ear, Inner; Epithelial Cells; Guanosine; Guinea Pigs; Hydrogen Peroxide; Injections, Intraperitoneal; Kidney Tubules; Kinetics; Microscopy, Fluorescence; Platinum; Rats; Stria Vascularis; Tissue Distribution

2006
Role of platinum-based radio-chemotherapy for locally advanced non-small-cell lung cancer: possible influence of type of platinum on survival data.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:11

    Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Humans; Lung Neoplasms; Meta-Analysis as Topic; Neoplasm Staging; Platinum; Survival Analysis

2006
Carboplatin nanocapsules: a highly cytotoxic, phospholipid-based formulation of carboplatin.
    Molecular cancer therapeutics, 2006, Volume: 5, Issue:8

    Topics: Carboplatin; Drug Compounding; Drug Screening Assays, Antitumor; Endocytosis; Humans; Nanoparticles; Phospholipids; Platinum; Structure-Activity Relationship; Tumor Cells, Cultured

2006
Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate.
    Journal of mass spectrometry : JMS, 2006, Volume: 41, Issue:9

    Topics: Antineoplastic Agents; Calibration; Carboplatin; Cisplatin; Humans; Indicators and Reagents; Mass Spectrometry; Organoplatinum Compounds; Oxaliplatin; Platinum; Quality Control; Reference Standards; Reproducibility of Results; Ultrafiltration

2006
Diagnostic and predictive value of skin testing in platinum salt hypersensitivity.
    The Journal of allergy and clinical immunology, 2007, Volume: 119, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Cisplatin; Cross Reactions; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Platinum; Prognosis; Prospective Studies; Salts; Skin Tests

2007
Evaluation of carboplatin pharmacokinetics in pediatric oncology by means of inductively coupled plasma mass spectrometry.
    Annali dell'Istituto superiore di sanita, 2006, Volume: 42, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Agents; Area Under Curve; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Female; Humans; Male; Mass Spectrometry; Myosarcoma; Neoplasms; Neoplasms, Muscle Tissue; Platinum; Rhabdomyosarcoma

2006
Treatment of non-small cell lung cancer, stage IIIB: ACCP evidence-based clinical practice guidelines (2nd edition).
    Chest, 2007, Volume: 132, Issue:3 Suppl

    Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cytotoxins; Evidence-Based Medicine; Humans; Lung Neoplasms; Neoplasm Staging; Paclitaxel; Platinum; Quality of Life; Treatment Outcome

2007
Accumulation, fractionation, and analysis of platinum in toxicologically affected tissues after cisplatin, oxaliplatin, and carboplatin administration.
    Journal of analytical toxicology, 2008, Volume: 32, Issue:2

    Topics: Animals; Antineoplastic Agents; Carboplatin; Cell Fractionation; Cisplatin; Cytosol; Ear, Inner; Kidney; Liver; Mass Spectrometry; Organoplatinum Compounds; Oxaliplatin; Platinum; Rats; Tissue Distribution

2008
Catheters for chronic administration of drugs into brain tissue.
    Methods in molecular biology (Clifton, N.J.), 2008, Volume: 437

    Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Brain; Brain Neoplasms; Carboplatin; Catheterization; Dogs; Doxorubicin; Drug Delivery Systems; Female; Glioma; Macaca fascicularis; Male; Neoplasm Transplantation; Neurosurgical Procedures; Pharmaceutical Preparations; Platinum; Rats; Rats, Inbred F344; Spectrophotometry, Atomic; Tissue Distribution

2008
Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes.
    Journal of inorganic biochemistry, 2008, Volume: 102, Issue:10

    Topics: Animals; Antineoplastic Agents; Carboplatin; Cell Line, Tumor; Cell Survival; Cisplatin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Male; Mice; Mice, Inbred BALB C; Organoplatinum Compounds; Platinum; Sarcoma; Sarcoma 180

2008
The role of the mammalian copper transporter 1 in the cellular accumulation of platinum-based drugs.
    Molecular pharmacology, 2009, Volume: 75, Issue:2

    Topics: Animals; Carboplatin; Cation Transport Proteins; Cell Line, Tumor; Cells, Cultured; Cisplatin; Copper Transporter 1; Mice; Organoplatinum Compounds; Oxaliplatin; Platinum

2009
Interstitial continuous infusion therapy in a malignant glioma model in rats.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2009, Volume: 25, Issue:6

    Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain; Brain Neoplasms; Carboplatin; Catheterization; Cell Line, Tumor; Corpus Striatum; Disease Models, Animal; Glioma; Kaplan-Meier Estimate; Male; Neoplasm Transplantation; Organoplatinum Compounds; Oxaliplatin; Platinum; Rats; Rats, Inbred F344; Treatment Outcome

2009
Targeted delivery of chemotherapeutic agents using improved radiosensitive liquid core microcapsules and assessment of their antitumor effect.
    International journal of radiation oncology, biology, physics, 2009, Oct-01, Volume: 75, Issue:2

    Topics: Alginates; Animals; Antineoplastic Agents; Calcium; Calcium Chloride; Capsules; Carboplatin; Cobalt Radioisotopes; Colorimetry; Combined Modality Therapy; Drug Compounding; Fibrosarcoma; Glucuronic Acid; Hexuronic Acids; Hyaluronic Acid; Mice; Mice, Inbred BALB C; Platinum; Polymers; Time Factors; Yttrium

2009
Peptide targeting of platinum anti-cancer drugs.
    Bioconjugate chemistry, 2009, Oct-21, Volume: 20, Issue:10

    Topics: Antineoplastic Agents; Apoptosis; Carboplatin; Caspases; CD13 Antigens; Cell Line, Tumor; DNA Fragmentation; Drug Delivery Systems; Female; Humans; Male; Molecular Targeted Therapy; Oligopeptides; Platinum

2009
Tumor platinum concentration following intraperitoneal administration of cisplatin versus carboplatin in an ovarian cancer model.
    Gynecologic oncology, 2009, Volume: 115, Issue:3

    Topics: Animals; Carboplatin; Cell Line, Tumor; Cisplatin; Cystadenocarcinoma, Serous; Female; Humans; Mice; Mice, Nude; Ovarian Neoplasms; Platinum; Transplantation, Heterologous

2009
Determination of platinum traces contamination by graphite furnace atomic absorption spectrometry after preconcentration by cloud point extraction.
    Journal of hazardous materials, 2010, Apr-15, Volume: 176, Issue:1-3

    Topics: Carboplatin; Chemical Precipitation; Cisplatin; Decontamination; Ditiocarb; Octoxynol; Organoplatinum Compounds; Oxaliplatin; Platinum; Platinum Compounds; Polyethylene Glycols; Spectrophotometry, Atomic

2010
On the many roles of NH3 ligands in mono- and multinuclear complexes of platinum.
    Dalton transactions (Cambridge, England : 2003), 2009, Dec-28, Issue:48

    Topics: Ammonia; Antineoplastic Agents; Carboplatin; Cisplatin; Coordination Complexes; Crystallography, X-Ray; Hydrogen Bonding; Ligands; Molecular Conformation; Platinum

2009
Gadolinium texaphyrin (Gd-Tex)-malonato-platinum conjugates: synthesis and comparison with carboplatin in normal and Pt-resistant cell lines.
    Dalton transactions (Cambridge, England : 2003), 2009, Dec-28, Issue:48

    Topics: Antineoplastic Agents; Carboplatin; Cell Line, Tumor; Coordination Complexes; Drug Resistance, Neoplasm; Humans; Metalloporphyrins; Platinum

2009
Synthesis, characterization, cytotoxicity, and DNA binding of some new platinum(II) and platinum(IV) complexes with benzimidazole ligands.
    Journal of enzyme inhibition and medicinal chemistry, 2010, Volume: 25, Issue:4

    Topics: Antineoplastic Agents; Benzimidazoles; Carboplatin; Cell Line, Tumor; Cisplatin; DNA; Humans; Ligands; Nucleic Acid Conformation; Organometallic Compounds; Plasmids; Platinum

2010
Population differences in platinum toxicity as a means to identify novel genetic susceptibility variants.
    Pharmacogenetics and genomics, 2010, Volume: 20, Issue:5

    Topics: Asian People; Black People; Carboplatin; Cell Line, Transformed; Cisplatin; Genetic Predisposition to Disease; Genetic Variation; Genetics, Population; Genome-Wide Association Study; Humans; Inhibitory Concentration 50; Lymphocytes; Pharmacogenetics; Phenotype; Platinum; White People

2010
Transcription inhibition by platinum-DNA cross-links in live mammalian cells.
    Journal of the American Chemical Society, 2010, Jun-02, Volume: 132, Issue:21

    Topics: Antineoplastic Agents; Base Sequence; Carboplatin; Cell Line, Tumor; Cisplatin; Cross-Linking Reagents; DNA; DNA Adducts; DNA Damage; DNA Repair; DNA-Directed RNA Polymerases; Genes, Reporter; Humans; Organoplatinum Compounds; Oxaliplatin; Plasmids; Platinum; Transcription, Genetic

2010
Genome-wide examination of genetic variants associated with response to platinum-based chemotherapy in patients with small-cell lung cancer.
    Pharmacogenetics and genomics, 2010, Volume: 20, Issue:6

    Topics: Carboplatin; Cisplatin; Etoposide; Female; Genes; Genome; Humans; Inuit; Lung Neoplasms; Male; Middle Aged; Nerve Tissue Proteins; Platinum; Polymorphism, Single Nucleotide; R-SNARE Proteins; Small Cell Lung Carcinoma

2010
Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy.
    Proceedings of the National Academy of Sciences of the United States of America, 2010, Jul-13, Volume: 107, Issue:28

    Topics: Animals; Carboplatin; Cisplatin; Inhibitory Concentration 50; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Nanoparticles; Nanotechnology; Neoplasms; Platinum; Polyenes; Polymers; Raloxifene Hydrochloride; Structure-Activity Relationship; Tissue Distribution

2010
Evaluation of in vitro cytotoxicity and hepatotoxicity of platinum(II) and palladium(II) oxalato complexes with adenine derivatives as carrier ligands.
    Journal of inorganic biochemistry, 2010, Volume: 104, Issue:10

    Topics: Adenine; Antineoplastic Agents; Carboplatin; Cell Line, Tumor; Cell Survival; Cells, Cultured; Cisplatin; HeLa Cells; Hepatocytes; Humans; Inhibitory Concentration 50; Molecular Structure; Organometallic Compounds; Organoplatinum Compounds; Oxaliplatin; Palladium; Platinum

2010
Determination of platinum originating from carboplatin in canine sebum and cerumen by inductively coupled plasma mass spectrometry.
    Journal of pharmaceutical and biomedical analysis, 2011, Jan-25, Volume: 54, Issue:2

    Topics: Animals; Antineoplastic Agents; Calibration; Carboplatin; Cerumen; Dogs; Humans; Indicators and Reagents; Limit of Detection; Platinum; Quality Control; Reference Standards; Reproducibility of Results; Sebum; Sensitivity and Specificity; Spectrum Analysis

2011
Second-line chemotherapy with docetaxel and carboplatin in paclitaxel and platinum-pretreated ovarian, fallopian tube, and peritoneal cancer.
    Medical oncology (Northwood, London, England), 2012, Volume: 29, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Drug Resistance, Neoplasm; Fallopian Tube Neoplasms; Female; Follow-Up Studies; Humans; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Platinum; Retrospective Studies; Salvage Therapy; Taxoids; Treatment Outcome

2012
Determination of platinum originating from carboplatin in human urine and canine excretion products by inductively coupled plasma mass spectrometry.
    Journal of analytical toxicology, 2011, Volume: 35, Issue:3

    Topics: Animals; Antineoplastic Agents; Carboplatin; Dogs; Feces; Humans; Platinum; Reproducibility of Results; Saliva; Spectrophotometry, Atomic

2011
Germline polymorphisms discovered via a cell-based, genome-wide approach predict platinum response in head and neck cancers.
    Translational research : the journal of laboratory and clinical medicine, 2011, Volume: 157, Issue:5

    Topics: Antineoplastic Agents; Biomarkers; Carboplatin; Cell Line; Genome-Wide Association Study; Head and Neck Neoplasms; Humans; Models, Biological; Platinum; Polymorphism, Genetic; Treatment Outcome

2011
Inelastic neutron scattering study of Pt(II) complexes displaying anticancer properties.
    Chemphyschem : a European journal of chemical physics and physical chemistry, 2011, May-09, Volume: 12, Issue:7

    Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Coordination Complexes; Neutron Diffraction; Platinum; Scattering, Small Angle

2011
Dialkyl bisphosphonate platinum(II) complex as a potential drug for metastatic bone tumor.
    Chemical & pharmaceutical bulletin, 2011, Volume: 59, Issue:6

    Topics: Adsorption; Antineoplastic Agents; Bone Neoplasms; Carboplatin; Cell Line, Tumor; Cisplatin; Coordination Complexes; Diphosphonates; Durapatite; Humans; Neoplasm Metastasis; Osteoclasts; Platinum

2011
Adamantane-platinum conjugate hosted in β-cyclodextrin: enhancing transport and cytotoxicity by noncovalent modification.
    Bioorganic & medicinal chemistry letters, 2011, Dec-15, Volume: 21, Issue:24

    Topics: Adamantane; Antineoplastic Agents; beta-Cyclodextrins; Carboplatin; Cell Line, Tumor; Cell Survival; Drug Carriers; Fluorescein-5-isothiocyanate; Humans; Mass Spectrometry; Microscopy, Confocal; Plasmids; Platinum

2011
Pharmacokinetics, tissue distribution, and plasma protein binding study of platinum originating from dicycloplatin, a novel antitumor supramolecule, in rats and dogs by ICP-MS.
    Biological trace element research, 2012, Volume: 148, Issue:2

    Topics: Animals; Antineoplastic Agents; Carboplatin; Dogs; Drug Combinations; Drug Screening Assays, Antitumor; Glutamates; Half-Life; Injections, Intravenous; Male; Mass Spectrometry; Organoplatinum Compounds; Platinum; Prostate; Protein Binding; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Testis; Time Factors; Tissue Distribution

2012
Urinary excretion of platinum, arsenic and selenium of cancer patients from the Antofagasta region in Chile treated with platinum-based drugs.
    BMC research notes, 2012, Apr-30, Volume: 5

    Topics: Antineoplastic Agents; Arsenic; Biomarkers; Carboplatin; Chile; Cisplatin; Cluster Analysis; Creatinine; Female; Humans; Linear Models; Lung Neoplasms; Male; Multivariate Analysis; Platinum; Selenium

2012
Capillary liquid chromatography with UV detection using N,N-diethyl dithiocarbamate for determining platinum-based antitumor drugs in plasma.
    Chemical & pharmaceutical bulletin, 2012, Volume: 60, Issue:5

    Topics: Animals; Antineoplastic Agents; Carboplatin; Chromatography, High Pressure Liquid; Cisplatin; Injections, Intraperitoneal; Male; Organoplatinum Compounds; Platinum; Rats; Rats, Wistar; Spectrophotometry, Ultraviolet; Thiocarbamates

2012
Tissue platinum concentration and tumor response in non-small-cell lung cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Sep-20, Volume: 30, Issue:27

    Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Platinum; Survival Analysis

2012
The interaction of platinum-based drugs with native biologically relevant proteins.
    Analytical and bioanalytical chemistry, 2013, Volume: 405, Issue:6

    Topics: Antineoplastic Agents; Carboplatin; Chromatography, Liquid; Cisplatin; Hemoglobins; Humans; Lactoglobulins; Organoplatinum Compounds; Oxaliplatin; Oxidation-Reduction; Platinum; Protein Binding; Serum Albumin; Sodium Chloride; Spectrometry, Mass, Electrospray Ionization; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2013
Theoretical investigations and density functional theory based quantitative structure-activity relationships model for novel cytotoxic platinum(IV) complexes.
    Journal of medicinal chemistry, 2013, 01-10, Volume: 56, Issue:1

    Topics: Antineoplastic Agents; Carboplatin; Cell Line, Tumor; Cisplatin; Coordination Complexes; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Ethylamines; Ethylenediamines; Humans; Models, Molecular; Molecular Conformation; Organoplatinum Compounds; Oxaliplatin; Platinum; Quantitative Structure-Activity Relationship; Thermodynamics

2013
Inductively coupled plasma mass-spectrometric determination of platinum in excretion products of client-owned pet dogs.
    Veterinary and comparative oncology, 2015, Volume: 13, Issue:2

    Topics: Animals; Antineoplastic Agents; Carboplatin; Cerumen; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Feces; Neoplasms; Platinum; Saliva; Sebum; Spectrophotometry, Atomic

2015
Platinum-based doublet chemotherapy plus bevacizumab without bevacizumab maintenance in advanced non-small cell lung cancer (NSCLC).
    Anticancer research, 2013, Volume: 33, Issue:8

    Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Maintenance Chemotherapy; Male; Middle Aged; Neoplasm Staging; Platinum; Vinblastine; Vinorelbine

2013
Caged Pt nanoclusters exhibiting corrodibility to exert tumor-inside activation for anticancer chemotherapeutics.
    Advanced materials (Deerfield Beach, Fla.), 2013, Sep-25, Volume: 25, Issue:36

    Topics: Animals; Antineoplastic Agents; Carboplatin; Cell Line, Tumor; Cell Survival; Cisplatin; Dendrimers; Drug Carriers; Humans; Magnetic Resonance Imaging; Mice; Mice, Nude; Nanostructures; Neoplasms; Platinum; Radiography; Transplantation, Heterologous

2013
Cost effectiveness of first-line pemetrexed plus platinum compared with other regimens in the treatment of patients with nonsquamous non-small cell lung cancer in the US outpatient setting.
    Lung cancer (Amsterdam, Netherlands), 2013, Volume: 82, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Disease-Free Survival; Female; Glutamates; Guanine; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Observational Studies as Topic; Pemetrexed; Platinum; Proportional Hazards Models; Retrospective Studies; Treatment Outcome; United States

2013
Determination of platinum surface contamination in veterinary and human oncology centres using inductively coupled plasma mass spectrometry.
    Veterinary and comparative oncology, 2015, Volume: 13, Issue:3

    Topics: Animals; Antineoplastic Agents; Cancer Care Facilities; Carboplatin; Environmental Monitoring; Equipment Contamination; Humans; Mass Spectrometry; Netherlands; Occupational Exposure; Platinum

2015
Combination studies of platinum(II)-based metallointercalators with buthionine-S,R-sulfoximine, 3-bromopyruvate, cisplatin or carboplatin.
    Metallomics : integrated biometal science, 2014, Volume: 6, Issue:1

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Buthionine Sulfoximine; Carboplatin; Cell Line; Cell Line, Tumor; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Synergism; Glutathione; Humans; Inhibitory Concentration 50; Molecular Structure; Neoplasms; Organoplatinum Compounds; Platinum; Pyruvates

2014
Endoplasmic reticulum stress is involved in the response of human laryngeal carcinoma cells to Carboplatin but is absent in Carboplatin-resistant cells.
    PloS one, 2013, Volume: 8, Issue:9

    Topics: Apoptosis; Blotting, Southwestern; Blotting, Western; Carboplatin; Carcinoma; Cell Line, Tumor; Cell Survival; Cinnamates; Cyclic N-Oxides; DNA Primers; Drug Resistance, Neoplasm; Endoplasmic Reticulum Stress; Gene Silencing; Humans; Laryngeal Neoplasms; Platinum; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Signal Transduction; Spin Labels; Thiourea

2013
A novel method for speciation of Pt in human serum incubated with cisplatin, oxaliplatin and carboplatin by conjoint liquid chromatography on monolithic disks with UV and ICP-MS detection.
    Talanta, 2013, Nov-15, Volume: 116

    Topics: Bacterial Proteins; Buffers; Carboplatin; Chromatography, High Pressure Liquid; Cisplatin; Humans; Hydrogen-Ion Concentration; Organoplatinum Compounds; Oxaliplatin; Platinum; Protein Binding; Reproducibility of Results; Sensitivity and Specificity; Serum Albumin; Spectrophotometry, Atomic; Transferrin

2013
TCEP-based rSDS-PAGE AND nLC-ESI-LTQ-MS/MS for oxaliplatin metalloproteomic analysis.
    Talanta, 2013, Nov-15, Volume: 116

    Topics: Animals; Carbonic Anhydrases; Carboplatin; Cisplatin; Cytochromes c; Electrophoresis, Polyacrylamide Gel; Kidney; Limit of Detection; Myoglobin; Organoplatinum Compounds; Oxaliplatin; Peptide Fragments; Phosphines; Platinum; Protein Binding; Proteolysis; Rats; Serum Albumin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tandem Mass Spectrometry; Transferrin; Trypsin

2013
DNA polymerase η modulates replication fork progression and DNA damage responses in platinum-treated human cells.
    Scientific reports, 2013, Nov-20, Volume: 3

    Topics: Carboplatin; Cell Cycle; Cell Line; Cisplatin; DNA Damage; DNA Replication; DNA-Directed DNA Polymerase; Drug Synergism; Gene Expression; Humans; Phosphorylation; Platinum; Replication Protein A

2013
Sequential extraction of platinum, cisplatin and carboplatin from environmental samples and pre-concentration/separation using vesicular coacervative extraction and determination by continuum source ETAAS.
    Talanta, 2014, Volume: 118

    Topics: Carboplatin; Chemical Fractionation; Cisplatin; Environmental Monitoring; Hydrochloric Acid; Molecular Structure; Nitric Acid; Platinum; Soil; Spectrophotometry, Atomic; Surface-Active Agents; Water

2014
East-west fusion-necrosis and apoptosis acting in concert by demethylcantharidin-integrated platinum complexes.
    Anti-cancer agents in medicinal chemistry, 2014, Volume: 14, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Cantharidin; Carboplatin; Cisplatin; Coordination Complexes; DNA Adducts; HCT116 Cells; Humans; Inhibitory Concentration 50; Light; Necrosis; Optical Imaging; Organoplatinum Compounds; Platinum; Pyridines; Scattering, Radiation

2014
Raman spectroscopic evaluation of DNA adducts of a platinum containing anticancer drug.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2014, Sep-15, Volume: 130

    Topics: Adenine; Animals; Antineoplastic Agents; Carboplatin; Cattle; Cisplatin; Cross-Linking Reagents; DNA; DNA Adducts; Guanine; Humans; Neoplasms; Nucleic Acid Conformation; Platinum; Protein Structure, Secondary; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Thymus Gland

2014
Synthesis, in-vitro cytotoxic activity and DNA interactions of new dicarboxylatoplatinum(II) complexes with 2-hydroxymethylbenzimidazole as carrier ligands.
    The Journal of pharmacy and pharmacology, 2014, Volume: 66, Issue:11

    Topics: Antineoplastic Agents; Benzimidazoles; Carboplatin; Cisplatin; DNA; Drug Screening Assays, Antitumor; Estrogens; HeLa Cells; Humans; In Vitro Techniques; Ligands; MCF-7 Cells; Neoplasms; Plasmids; Platinum; Progesterone; Progestins; Restriction Mapping

2014
[Effects of hyperthermia combined platinum-based drugs on ovarian cancer cell lines SKOV3].
    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2014, Volume: 45, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Carboplatin; Cell Line; Cell Line, Tumor; Cell Proliferation; Cisplatin; DNA-Binding Proteins; Down-Regulation; Drug Resistance, Neoplasm; Endonucleases; Female; Hot Temperature; Humans; Inhibitor of Apoptosis Proteins; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Platinum; RNA, Messenger; Survivin

2014
A shotgun approach for the identification of platinum-protein complexes.
    Analytical and bioanalytical chemistry, 2015, Volume: 407, Issue:9

    Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Humans; Male; Organoplatinum Compounds; Oxaliplatin; Peptides; Platinum; Protein Binding; Proteins; Tandem Mass Spectrometry

2015
Long-term platinum retention after platinum-based chemotherapy in testicular cancer survivors: a 20-year follow-up study.
    Anticancer research, 2015, Volume: 35, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carboplatin; Cisplatin; Follow-Up Studies; Humans; Male; Middle Aged; Platinum; Testicular Neoplasms

2015
Mono- and di-bromo platinum(IV) prodrugs via oxidative bromination: synthesis, characterization, and cytotoxicity.
    Dalton transactions (Cambridge, England : 2003), 2015, Dec-14, Volume: 44, Issue:46

    Topics: Antineoplastic Agents; Bromosuccinimide; Carboplatin; Cell Line, Tumor; Cisplatin; Female; Halogenation; Humans; Models, Molecular; Organoplatinum Compounds; Ovarian Neoplasms; Ovary; Oxaliplatin; Oxidation-Reduction; Platinum; Prodrugs

2015
The role of the equatorial ligands for the redox behavior, mode of cellular accumulation and cytotoxicity of platinum(IV) prodrugs.
    Journal of inorganic biochemistry, 2016, Volume: 160

    Topics: Adenosine Triphosphate; Antineoplastic Agents; Biological Transport; Carboplatin; Cell Line, Tumor; Cell Survival; Cisplatin; Cold Temperature; Coordination Complexes; Glucose; Hep G2 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Ligands; Oligomycins; Organoplatinum Compounds; Oxidation-Reduction; Platinum; Prodrugs; Structure-Activity Relationship

2016
Dual mTORC1/2 Inhibition as a Novel Strategy for the Resensitization and Treatment of Platinum-Resistant Ovarian Cancer.
    Molecular cancer therapeutics, 2016, Volume: 15, Issue:7

    Topics: Allosteric Regulation; Animals; Antineoplastic Agents; Carboplatin; Catalytic Domain; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Drug Resistance, Neoplasm; Everolimus; Female; Humans; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Multiprotein Complexes; Ovarian Neoplasms; Platinum; Protein Kinase Inhibitors; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2016
The Development of an Angiogenic Protein "Signature" in Ovarian Cancer Ascites as a Tool for Biologic and Prognostic Profiling.
    PloS one, 2016, Volume: 11, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Ascites; Ascitic Fluid; Carboplatin; Female; Humans; Middle Aged; Neovascularization, Pathologic; Ovarian Neoplasms; Platinum; Prognosis; Vascular Endothelial Growth Factor A

2016
Nanoscale Coordination Polymers Codeliver Carboplatin and Gemcitabine for Highly Effective Treatment of Platinum-Resistant Ovarian Cancer.
    Molecular pharmaceutics, 2016, 11-07, Volume: 13, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Line, Tumor; Deoxycytidine; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Nanoparticles; Ovarian Neoplasms; Platinum; Polymers; Treatment Outcome

2016
Platinum desensitization in patients with carboplatin hypersensitivity: A single-institution retrospective study.
    Gynecologic oncology, 2017, Volume: 144, Issue:1

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Carboplatin; Desensitization, Immunologic; Drug Hypersensitivity; Female; Genital Neoplasms, Female; Humans; Middle Aged; Platinum; Retrospective Studies; Skin Tests

2017
Elution of platinum from carboplatin-impregnated calcium sulfate hemihydrate beads in vitro.
    American journal of veterinary research, 2016, Volume: 77, Issue:11

    Topics: Animals; Calcium Sulfate; Carboplatin; Microspheres; Platinum

2016
Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, Potentiates the Activity of Standard of Care Therapeutics in Ovarian Cancer Models.
    Neoplasia (New York, N.Y.), 2016, Volume: 18, Issue:12

    Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Carboplatin; Cell Cycle; Cell Line, Tumor; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Synergism; Female; Folate Receptor 1; Humans; Immunoconjugates; Maytansine; Mice; Neovascularization, Pathologic; Ovarian Neoplasms; Platinum; Xenograft Model Antitumor Assays

2016
Microdose-Induced Drug-DNA Adducts as Biomarkers of Chemotherapy Resistance in Humans and Mice.
    Molecular cancer therapeutics, 2017, Volume: 16, Issue:2

    Topics: Animals; Antineoplastic Agents; Biomarkers; Carboplatin; Cell Line, Tumor; Deoxycytidine; Disease Models, Animal; DNA Adducts; DNA Repair; Drug Resistance, Neoplasm; Drug Synergism; Female; Gemcitabine; Humans; Mass Spectrometry; Mice; Mutation; Neoplasms; Platinum; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays

2017
Chemical Imaging of Platinum-Based Drugs and their Metabolites.
    Scientific reports, 2016, 12-05, Volume: 6

    Topics: Carboplatin; Chromatography, Liquid; Cisplatin; Culture Media; Ditiocarb; HCT116 Cells; Humans; Hyperthermia, Induced; Imaging, Three-Dimensional; Metabolome; Organoplatinum Compounds; Oxaliplatin; Pharmaceutical Preparations; Platinum; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Spheroids, Cellular; Tandem Mass Spectrometry; Time Factors

2016
Anticancer activity and tissue distribution of platinum (II) complex with lignin-derived polymer of benzene-poly-carboxylic acids.
    Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS), 2017, Volume: 43

    Topics: Animals; Antineoplastic Agents; Benzene; Carboplatin; Carboxylic Acids; Carcinoma, Ehrlich Tumor; Cisplatin; Female; Lignin; Mice; Organoplatinum Compounds; Platinum; Polymers

2017
Picking the Right Patient for Human Epidermal Growth Factor Receptor 3-Targeted Therapy in Platinum-Resistant Ovarian Cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, 12-20, Volume: 34, Issue:36

    Topics: Carboplatin; Drug Resistance, Neoplasm; ErbB Receptors; Female; Humans; Ovarian Neoplasms; Platinum

2016
Biological Recovery of Platinum Complexes from Diluted Aqueous Streams by Axenic Cultures.
    PloS one, 2017, Volume: 12, Issue:1

    Topics: Antineoplastic Agents; Axenic Culture; Carboplatin; Cisplatin; Cupriavidus; Environmental Monitoring; Environmental Pollutants; Environmental Restoration and Remediation; Flow Cytometry; Geobacter; Microbial Viability; Microscopy, Electron, Transmission; Platinum; Platinum Compounds; Shewanella; Wastewater; Water Purification

2017
Characterization of long-term elution of platinum from carboplatin-impregnated calcium sulfate hemihydrate beads in vitro by two distinct sample collection methods.
    American journal of veterinary research, 2017, Volume: 78, Issue:5

    Topics: Animals; Antineoplastic Agents; Calcium Sulfate; Carboplatin; Drug Delivery Systems; Microspheres; Platinum

2017
Effect of GSTP1 and ABCC2 Polymorphisms on Treatment Response in Patients with Advanced Non-Small Cell Lung Cancer Undergoing Platinum-Based Chemotherapy: A Study in a Chinese Uygur Population.
    Medical science monitor : international medical journal of experimental and clinical research, 2017, Apr-26, Volume: 23

    Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; China; Cisplatin; Disease-Free Survival; Ethnicity; Female; Glutathione S-Transferase pi; Humans; Lung Neoplasms; Male; Middle Aged; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Platinum; Polymorphism, Single Nucleotide; Prognosis; Treatment Outcome

2017
Platinum-induced mitochondrial DNA mutations confer lower sensitivity to paclitaxel by impairing tubulin cytoskeletal organization.
    Human molecular genetics, 2017, 08-01, Volume: 26, Issue:15

    Topics: Antineoplastic Agents; Carboplatin; Cell Line, Tumor; Cytoskeleton; DNA, Mitochondrial; Drug Resistance, Neoplasm; Female; Humans; Mutation; Ovarian Neoplasms; Paclitaxel; Platinum; Tubulin

2017
[
    International journal of molecular sciences, 2017, May-18, Volume: 18, Issue:5

    Topics: Animals; Carboplatin; Drug Delivery Systems; Female; Liposomes; Mice; Platinum; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon

2017
Mass spectrometry-based serum peptidome profiling accurately and reliably predicts outcomes of pemetrexed plus platinum chemotherapy in patients with advanced lung adenocarcinoma.
    PloS one, 2017, Volume: 12, Issue:6

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Carboplatin; Disease-Free Survival; Female; Humans; Lung Neoplasms; Male; Mass Spectrometry; Middle Aged; Pemetrexed; Peptides; Platinum; Retrospective Studies; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2017
DNA interaction with platinum-based cytostatics revealed by DNA sequencing.
    Analytical biochemistry, 2017, 12-15, Volume: 539

    Topics: Carboplatin; Cisplatin; Cytostatic Agents; DNA; DNA Adducts; Mass Spectrometry; Organoplatinum Compounds; Oxaliplatin; Platinum; Polymerase Chain Reaction; Sequence Analysis, DNA

2017
DN604: A platinum(II) drug candidate with classic SAR can induce apoptosis via suppressing CK2-mediated p-cdc25C subcellular localization in cancer cells.
    Experimental cell research, 2018, 03-01, Volume: 364, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Carboplatin; cdc25 Phosphatases; Cell Cycle Checkpoints; Cell Proliferation; Checkpoint Kinase 2; Colonic Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Platinum; Stomach Neoplasms; Structure-Activity Relationship; Subcellular Fractions; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2018
Development of a carboplatin derivative conjugated with a collagen-like triple-helical peptide.
    Future medicinal chemistry, 2018, 03-01, Volume: 10, Issue:6

    Topics: Animals; Carboplatin; Cell Line, Tumor; Cell Survival; Cell-Penetrating Peptides; Collagen; Drug Design; Drug Stability; Half-Life; Humans; Male; Malonates; Mice; Mice, Inbred ICR; Neoplasms; Platinum; Prodrugs; Protein Structure, Secondary; Survival Rate; Transplantation, Heterologous

2018
Development of a novel carboplatin like cytoplasmic trackable near infrared fluorophore conjugate via strain-promoted azide alkyne cycloaddition.
    Journal of inorganic biochemistry, 2018, Volume: 182

    Topics: Antineoplastic Agents; Azides; Carboplatin; Cell Line, Tumor; Cell Survival; Click Chemistry; Cycloaddition Reaction; Cytoplasm; Humans; Platinum

2018
Addition of platinum salts to neoadjuvant chemotherapy in triple-negative breast cancer: a new standard of care?
    The Lancet. Oncology, 2018, Volume: 19, Issue:4

    Topics: Benzimidazoles; Carboplatin; Humans; Neoadjuvant Therapy; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Salts; Standard of Care; Triple Negative Breast Neoplasms

2018
Retrospective analysis of the survival benefit of chemotherapy for recurrent or advanced epithelial ovarian carcinoma in patients previously treated with paclitaxel plus platinum-based chemotherapy.
    European journal of gynaecological oncology, 2016, Volume: 37, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Ovarian Epithelial; Disease-Free Survival; Humans; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Platinum; Retrospective Studies

2016
Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy.
    Science translational medicine, 2018, 07-25, Volume: 10, Issue:451

    Topics: A549 Cells; Activins; Adenocarcinoma of Lung; Animals; Carboplatin; Cell Line, Tumor; Cell Survival; Follistatin; Humans; Lung Neoplasms; Male; Mice; Platinum; Signal Transduction; Xenograft Model Antitumor Assays

2018
Raman and Infrared Studies of Platinum-Based Drugs: Cisplatin, Carboplatin, Oxaliplatin, Nedaplatin, and Heptaplatin.
    The journal of physical chemistry. A, 2018, Aug-30, Volume: 122, Issue:34

    Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Malonates; Models, Chemical; Molecular Conformation; Organoplatinum Compounds; Oxaliplatin; Platinum; Quantum Theory; Spectrophotometry, Infrared; Spectrum Analysis, Raman; Stereoisomerism; Vibration

2018
Simulation of spatial diffusion of platinum from carboplatin-impregnated calcium sulfate hemihydrate beads by use of an agarose gelatin tissue phantom.
    American journal of veterinary research, 2018, Volume: 79, Issue:6

    Topics: Animals; Calcium Sulfate; Carboplatin; Dogs; Drug Screening Assays, Antitumor; Gelatin; Inhibitory Concentration 50; Mass Spectrometry; Microspheres; Neoplasms; Phantoms, Imaging; Platinum; Sepharose; Time Factors

2018
Correlation of Platinum Cytotoxicity to Drug-DNA Adduct Levels in a Breast Cancer Cell Line Panel.
    Chemical research in toxicology, 2018, 12-17, Volume: 31, Issue:12

    Topics: Breast Neoplasms; Carboplatin; Cell Line, Tumor; Coordination Complexes; DNA Adducts; DNA Damage; DNA Repair; Female; Humans; Mass Spectrometry; Oxaliplatin; Platinum

2018
Transport of platinum-based pharmaceuticals in water-saturated sand and natural soil: Carboplatin and cisplatin species.
    Chemosphere, 2019, Volume: 219

    Topics: Biopharmaceutics; Carboplatin; Cisplatin; Geologic Sediments; Organoplatinum Compounds; Oxidation-Reduction; Platinum; Platinum Compounds; Soil; Soil Pollutants; Water

2019
A comparison of the Muenster, SIOP Boston, Brock, Chang and CTCAEv4.03 ototoxicity grading scales applied to 3,799 audiograms of childhood cancer patients treated with platinum-based chemotherapy.
    PloS one, 2019, Volume: 14, Issue:2

    Topics: Antineoplastic Agents; Audiometry; Carboplatin; Child; Cisplatin; Female; Hearing Loss; Humans; Male; Neoplasms; Platinum

2019
Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.
    BMC cancer, 2019, Feb-21, Volume: 19, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cohort Studies; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Platinum; Predictive Value of Tests; Prognosis; Survival Analysis; Treatment Outcome

2019
A Triangular Platinum(II) Multinuclear Complex with Cytotoxicity Towards Breast Cancer Stem Cells.
    Angewandte Chemie (International ed. in English), 2019, 08-26, Volume: 58, Issue:35

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cadherins; Carboplatin; Caspases; Cell Line, Tumor; Cisplatin; Coordination Complexes; Crystallography, X-Ray; Female; Humans; Molecular Conformation; Neoplastic Stem Cells; Platinum; Pyrans; RNA Interference; RNA, Small Interfering

2019
The leading established metal-based drugs: a revisitation of their relevant physico-chemical data.
    Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2019, Volume: 32, Issue:5

    Topics: Auranofin; Carboplatin; Cisplatin; Coordination Complexes; Gold; Gold Sodium Thiomalate; Merbromin; Mercury; Oxaliplatin; Phenylmercury Compounds; Platinum; Ruthenium

2019
Is Gefitinib Combined With Platinum-Doublet Chemotherapy a Counterpart to Osimertinib Monotherapy in Advanced
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020, 03-10, Volume: 38, Issue:8

    Topics: Acrylamides; Aniline Compounds; Carboplatin; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Gefitinib; Humans; Lung Neoplasms; Pemetrexed; Platinum

2020
Pharmacokinetics of platinum and safety evaluation of carboplatin-impregnated calcium sulfate hemihydrate beads after implantation in healthy cats.
    Veterinary surgery : VS, 2020, Volume: 49, Issue:4

    Topics: Animals; Antineoplastic Agents; Calcium Sulfate; Carboplatin; Cats; Female; Platinum

2020
Potential use of n-3 PUFAs to prevent oxidative stress-derived ototoxicity caused by platinum-based chemotherapy.
    Free radical biology & medicine, 2020, 11-20, Volume: 160

    Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Fatty Acids, Omega-3; Humans; Ototoxicity; Oxidative Stress; Platinum

2020
Flavonoids Restore Platinum Drug Sensitivity to Ovarian Carcinoma Cells in a Phospho-ERK1/2-Dependent Fashion.
    International journal of molecular sciences, 2020, Sep-07, Volume: 21, Issue:18

    Topics: 3T3-L1 Cells; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Flavonoids; Humans; MAP Kinase Signaling System; Mice; Ovarian Neoplasms; Paclitaxel; Platinum; Tumor Microenvironment

2020
Checkpoint Kinase 1 Pharmacological Inhibition Synergizes with DNA-Damaging Agents and Overcomes Platinum Resistance in Basal-Like Breast Cancer.
    International journal of molecular sciences, 2020, Nov-27, Volume: 21, Issue:23

    Topics: Apoptosis; Breast Neoplasms; Carboplatin; Caspases; Cell Line, Tumor; Cell Proliferation; Checkpoint Kinase 1; Cisplatin; Deoxycytidine; DNA Damage; Drug Resistance, Neoplasm; Drug Synergism; Female; Gemcitabine; Humans; Neoplasm Invasiveness; Platinum

2020
Chloroxine overrides DNA damage tolerance to restore platinum sensitivity in high-grade serous ovarian cancer.
    Cell death & disease, 2021, 04-14, Volume: 12, Issue:4

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chloroquinolinols; Cisplatin; Cystadenocarcinoma, Serous; DNA Damage; Drug Resistance, Neoplasm; Female; Humans; Mice, Transgenic; Ovarian Neoplasms; Platinum

2021
Treatment-related leukemia after taxane and platinum therapy in gynecological cancer patients (Gynecologic Oncology Trial and Investigation Consortium 011).
    The journal of obstetrics and gynaecology research, 2021, Volume: 47, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Genital Neoplasms, Female; Humans; Leukemia; Ovarian Neoplasms; Paclitaxel; Platinum; Retrospective Studies; Taxoids

2021
Comparisons of segment-specific toxicity of platinum-based agents and cadmium using S1, S2, and S3 cells derived from mouse kidney proximal tubules.
    Toxicology in vitro : an international journal published in association with BIBRA, 2021, Volume: 75

    Topics: Animals; Antineoplastic Agents; Cadmium; Cadmium Chloride; Carboplatin; Cell Survival; Cells, Cultured; Cisplatin; Clusterin; Copper Transporter 1; Hepatitis A Virus Cellular Receptor 1; Kidney Tubules, Proximal; Mice; Organic Cation Transport Proteins; Organic Cation Transporter 2; Oxaliplatin; Platinum

2021
Platinum-based chemotherapy and bevacizumab instigate the destruction of human ovarian cancers via different signaling pathways.
    Biochemical pharmacology, 2021, Volume: 188

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Platinum; Signal Transduction; Tumor Cells, Cultured

2021
Pharmacokinetic and safety assessment of carboplatin-impregnated calcium sulfate hemihydrate beads in eight rats.
    Veterinary surgery : VS, 2021, Volume: 50, Issue:8

    Topics: Animals; Calcium Sulfate; Carboplatin; Male; Platinum; Rats; Rats, Sprague-Dawley

2021
Adavosertib with Chemotherapy in Patients with Primary Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: An Open-Label, Four-Arm, Phase II Study.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2022, 01-01, Volume: 28, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Fallopian Tubes; Female; Humans; Ovarian Neoplasms; Paclitaxel; Platinum; Pyrazoles; Pyrimidinones

2022
Cisplatin-Based versus Carboplatin-Based Chemotherapy for Extrapulmonary Neuroendocrine Carcinomas: A Real-World Study.
    Neuroendocrinology, 2022, Volume: 112, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Humans; Lung Neoplasms; Platinum

2022
A retrospective study on optimal number of cycles of the first-line platinum-based chemotherapy for metastatic urothelial carcinoma.
    Urologic oncology, 2022, Volume: 40, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Female; Humans; Male; Middle Aged; Platinum; Retrospective Studies; Urinary Bladder Neoplasms

2022
Platinum rechallenge treatment using gemcitabine plus carboplatin with or without bevacizumab for platinum-resistant ovarian cancer.
    International journal of clinical oncology, 2022, Volume: 27, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Deoxycytidine; Gemcitabine; Humans; Ovarian Neoplasms; Platinum

2022
Long-term auditory follow-up in the management of pediatric platinum-induced ototoxicity.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2022, Volume: 279, Issue:10

    Topics: Antineoplastic Agents; Carboplatin; Child; Cisplatin; Follow-Up Studies; Hearing Loss; Humans; Ototoxicity; Platinum; Platinum Compounds

2022
Platinum-Based Chemotherapy 'Rechallenge' in Advanced Non-ovarian Solid Malignancies.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2022, Volume: 34, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Female; Humans; Lung Neoplasms; Ovarian Neoplasms; Platinum; Quality of Life

2022
Enhancing Circulation and Tumor Accumulation of Carboplatin via an Erythrocyte-Anchored Prodrug Strategy.
    Angewandte Chemie (International ed. in English), 2022, 06-20, Volume: 61, Issue:25

    Topics: Animals; Antineoplastic Agents; Carboplatin; Cell Line, Tumor; Cisplatin; Erythrocytes; Mice; Neoplasms; Platinum; Prodrugs

2022
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma.
    International journal of cancer, 2022, 08-15, Volume: 151, Issue:4

    Topics: Biomarkers, Tumor; Carboplatin; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Humans; Neoplasm Staging; Neural Cell Adhesion Molecule L1; Platinum; Prognosis

2022
Clinical efficacy and safety of pemetrexed with or without either Bevacizumab or Pembrolizumab in patients with metastatic nonsquamous non-small cell carcinoma.
    Asia-Pacific journal of clinical oncology, 2023, Volume: 19, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Humans; Lung Neoplasms; Pemetrexed; Platinum; Retrospective Studies; Treatment Outcome

2023
Anaphylactic reaction to carboplatin diagnosed by skin testing-a reliable tool in platinum-based immediate-type hypersensitivity reactions.
    Wiener medizinische Wochenschrift (1946), 2023, Volume: 173, Issue:11-12

    Topics: Anaphylaxis; Antineoplastic Agents; Carboplatin; Cisplatin; Drug Hypersensitivity; Erythema; Female; Humans; Melanoma; Middle Aged; Ovarian Neoplasms; Platinum

2023
Severity of hearing loss after platinum chemotherapy in childhood cancer survivors.
    Pediatric blood & cancer, 2022, Volume: 69, Issue:9

    Topics: Antineoplastic Agents; Cancer Survivors; Carboplatin; Child; Cisplatin; Hearing Loss; Humans; Neoplasms; Platinum

2022
Fibroblast growth factor signalling influences homologous recombination-mediated DNA damage repair to promote drug resistance in ovarian cancer.
    British journal of cancer, 2022, Volume: 127, Issue:7

    Topics: Ataxia Telangiectasia Mutated Proteins; Carboplatin; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cisplatin; DNA Damage; DNA Repair; DNA-Activated Protein Kinase; Drug Resistance; Female; Fibroblast Growth Factor 1; Fibroblast Growth Factors; Humans; Ovarian Neoplasms; Platinum; Recombinational DNA Repair; Replication Protein A; RNA, Small Interfering

2022
Influence of first-line chemotherapy regimen on survival outcomes of patients with advanced urothelial carcinoma who received second-line immune checkpoint inhibitors.
    Urologic oncology, 2022, Volume: 40, Issue:10

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Humans; Immune Checkpoint Inhibitors; Platinum; Retrospective Studies; Urinary Bladder Neoplasms

2022
Sensitization of cancer cells towards Cisplatin and Carboplatin by protein kinase D inhibitors through modulation of ATP7A/B (copper transport ATPases).
    Cancer treatment and research communications, 2022, Volume: 32

    Topics: Adenosine Triphosphatases; Antineoplastic Agents; Carboplatin; Cation Transport Proteins; Cisplatin; Copper; Copper-Transporting ATPases; Drug Resistance, Neoplasm; Humans; Neoplasms; Peptide Fragments; Platinum; Protein Kinase C; Protein Kinase Inhibitors

2022
A novel cell line panel reveals non-genetic mediators of platinum resistance and phenotypic diversity in high grade serous ovarian cancer.
    Gynecologic oncology, 2022, Volume: 167, Issue:1

    Topics: Carboplatin; Carcinoma, Ovarian Epithelial; Cell Line; Cisplatin; Drug Resistance, Neoplasm; Female; Humans; Ovarian Neoplasms; Platinum; Tumor Microenvironment

2022
Ruthenium(II) Polypyridyl Complexes Containing Simple Dioxo Ligands: a Structure-Activity Relationship Study Shows the Importance of the Charge.
    Chembiochem : a European journal of chemical biology, 2022, 10-06, Volume: 23, Issue:19

    Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Coordination Complexes; Humans; Ligands; Malonates; Neoplasms; Oxalates; Platinum; Ruthenium; Structure-Activity Relationship

2022
Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.
    Thoracic cancer, 2022, Volume: 13, Issue:19

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Platinum; Small Cell Lung Carcinoma

2022
Mutational Footprint of Platinum Chemotherapy in a Secondary Thyroid Cancer.
    JCO precision oncology, 2022, Volume: 6

    Topics: Carboplatin; Female; Humans; Ovarian Neoplasms; Platinum; Thyroid Neoplasms

2022
Safety and efficacy of anlotinib in combination with standard chemotherapy as first-line treatment for extensive-stage small cell lung cancer: A multi-center, prospective study (ACTION-2).
    Lung cancer (Amsterdam, Netherlands), 2022, Volume: 173

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Humans; Lung Neoplasms; Platinum; Prospective Studies; Small Cell Lung Carcinoma; Treatment Outcome

2022
Potent Chlorambucil-Platinum(IV) Prodrugs.
    International journal of molecular sciences, 2022, Sep-09, Volume: 23, Issue:18

    Topics: Antineoplastic Agents; Carboplatin; Cell Line, Tumor; Chlorambucil; Cisplatin; Female; Humans; Male; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Platinum; Prodrugs; Reactive Oxygen Species

2022
Cost Effectiveness of Adding Pembrolizumab to Platinum and Fluoropyrimidine-Based Chemotherapy as First-Line Treatment for Advanced Esophageal Cancer: A US Healthcare Payer's Perspective.
    PharmacoEconomics, 2022, Volume: 40, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cost-Benefit Analysis; Delivery of Health Care; Esophageal Neoplasms; Fluorouracil; Humans; Paclitaxel; Platinum; Quality-Adjusted Life Years; Trastuzumab

2022
Platinum-induced ototoxicity in pediatric cancer survivors: GSTP1 c.313A>G variant association.
    Medicine, 2022, Nov-11, Volume: 101, Issue:45

    Topics: Cancer Survivors; Carboplatin; Child; Cisplatin; Cross-Sectional Studies; Deafness; Glutathione S-Transferase pi; Hearing Loss; Humans; Neoplasms; Ototoxicity; Platinum

2022
Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism.
    Journal of translational medicine, 2022, 12-03, Volume: 20, Issue:1

    Topics: Aldehyde Reductase; Carboplatin; Carcinoma, Ovarian Epithelial; CD8-Positive T-Lymphocytes; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Female; Humans; Ovarian Neoplasms; Platinum; Proteomics; RNA, Messenger; Tumor Microenvironment

2022
Loss of the volume-regulated anion channel components LRRC8A and LRRC8D limits platinum drug efficacy.
    Cancer research communications, 2022, 10-26, Volume: 2, Issue:10

    Topics: Animals; Anions; Carboplatin; Cisplatin; Membrane Proteins; Mice; Platinum; Prospective Studies; Tumor Suppressor Protein p53

2022
Real-world comparison of survival outcomes with cisplatin versus carboplatin in patients with limited-stage small-cell lung cancer.
    Cancer treatment and research communications, 2023, Volume: 35

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Humans; Lung Neoplasms; Platinum; Small Cell Lung Carcinoma; Treatment Outcome

2023
Therapeutic efficacy of platinum/etoposide regimens in the treatment of advanced poorly differentiated neuroendocrine carcinomas of the lung: A retrospective analysis.
    Frontiers in endocrinology, 2023, Volume: 14

    Topics: Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Humans; Lung; Lung Neoplasms; Neuroendocrine Tumors; Platinum; Retrospective Studies

2023
Real-world evaluation of atezolizumab and etoposide-carboplatin as a first-line treatment for extensive-stage small cell lung cancer.
    The Korean journal of internal medicine, 2023, Volume: 38, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Lung Neoplasms; Platinum; Retrospective Studies; Small Cell Lung Carcinoma

2023
Effectiveness and safety of nab-paclitaxel and platinum as first-line chemotherapy for ovarian cancer: a retrospective study.
    Journal of gynecologic oncology, 2023, Volume: 34, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Platinum; Retrospective Studies

2023
Efficacy and Safety of Platinum-based Chemotherapy With Bevacizumab Followed by Bevacizumab Maintenance for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer During PARP Inhibitor Therapy: A Multicenter Retrospective Study.
    Anticancer research, 2023, Volume: 43, Issue:3

    Topics: Adenosine Diphosphate Ribose; Bevacizumab; Carboplatin; Carcinoma, Ovarian Epithelial; Fallopian Tubes; Female; Humans; Neutropenia; Ovarian Neoplasms; Paclitaxel; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Retrospective Studies; Thrombocytopenia

2023
Effect of Mirtazapine for the Prevention of Nausea and Vomiting in Patients With Thoracic Cancer Receiving Platinum-based Chemotherapy.
    Anticancer research, 2023, Volume: 43, Issue:3

    Topics: Antiemetics; Carboplatin; Humans; Mirtazapine; Nausea; Platinum; Retrospective Studies; Serotonin; Thoracic Neoplasms; Vomiting

2023
The PARP1 Inhibitor AZD5305 Impairs Ovarian Adenocarcinoma Progression and Visceral Metastases in Patient-derived Xenografts Alone and in Combination with Carboplatin.
    Cancer research communications, 2023, Volume: 3, Issue:3

    Topics: Adenocarcinoma; Animals; BRCA2 Protein; Carboplatin; Carcinoma, Ovarian Epithelial; Disease Models, Animal; Female; Heterografts; Humans; Mice; Ovarian Neoplasms; Platinum; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors

2023
First-line cetuximab + platinum-based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real-world observational study-ENCORE.
    Cancer reports (Hoboken, N.J.), 2023, Volume: 6, Issue:5

    Topics: Carboplatin; Cetuximab; Cisplatin; Fluorouracil; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Platinum; Prospective Studies; Squamous Cell Carcinoma of Head and Neck

2023
Secreted Soluble Factors from Tumor-Activated Mesenchymal Stromal Cells Confer Platinum Chemoresistance to Ovarian Cancer Cells.
    International journal of molecular sciences, 2023, Apr-23, Volume: 24, Issue:9

    Topics: Animals; Carboplatin; Drug Resistance, Neoplasm; Female; Humans; Mesenchymal Stem Cells; Mice; Ovarian Neoplasms; Platinum; Tumor Microenvironment

2023
Comparative study on removal of platinum cytostatic drugs at trace level by cysteine, diethylenetriamino functionalized Si-gels and polyethyleneimine functionalized sponge: Adsorption performance and mechanisms.
    The Science of the total environment, 2023, Sep-15, Volume: 891

    Topics: Adsorption; Carboplatin; Cisplatin; Cysteine; Cytostatic Agents; DEET; Hydrogen-Ion Concentration; Kinetics; Platinum; Polyethyleneimine; Silica Gel; Thermodynamics; Water; Water Pollutants, Chemical

2023
The combination of etoposide and platinum for the treatment of thymic neuroendocrine neoplasms: A retrospective analysis.
    Cancer medicine, 2023, Volume: 12, Issue:15

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Humans; Lung Neoplasms; Neuroendocrine Tumors; Platinum; Retrospective Studies

2023
Clinical and Economic Outcomes in Patients With Metastatic Urothelial Carcinoma Receiving First-Line Systemic Treatment (the IMPACT UC I Study).
    The oncologist, 2023, 09-07, Volume: 28, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Humans; Medicare; Platinum; Retrospective Studies; United States; Urinary Bladder Neoplasms

2023
Binding Motifs of Carboplatin and Oxaliplatin with Guanine: A Combined MS/MS, IRMPD, and Theoretical Study.
    Inorganic chemistry, 2023, Sep-11, Volume: 62, Issue:36

    Topics: Carboplatin; Guanine; Oxaliplatin; Platinum; Spectrophotometry, Infrared; Tandem Mass Spectrometry

2023
Efficacy of paclitaxel-carboplatin with bevacizumab as a late-line therapy for patients with advanced nonsquamous non-small cell lung cancer: A platinum rechallenge.
    Thoracic cancer, 2023, Volume: 14, Issue:31

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Paclitaxel; Platinum; Retrospective Studies

2023
Therapeutic dosing and targeting efficacy of Pt-Mal-LHRH towards triple negative breast cancer.
    PloS one, 2023, Volume: 18, Issue:10

    Topics: Antineoplastic Agents; Carboplatin; Cell Line, Tumor; Female; Gonadotropin-Releasing Hormone; Humans; Platinum; Receptors, LHRH; Triple Negative Breast Neoplasms

2023
Atezolizumab addition to platinum doublet: evaluating survival outcomes for patients with extensive disease small cell lung cancer.
    Journal of cancer research and clinical oncology, 2023, Volume: 149, Issue:19

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Humans; Lung Neoplasms; Male; Platinum; Retrospective Studies; Small Cell Lung Carcinoma

2023
H-Dot Mediated Nanotherapeutics Mitigate Systemic Toxicity of Platinum-Based Anticancer Drugs.
    International journal of molecular sciences, 2023, Oct-23, Volume: 24, Issue:20

    Topics: Animals; Antineoplastic Agents; Carboplatin; Cardiotoxicity; Cisplatin; Neoplasms; Platinum

2023
Analysis of platinum-based anticancer injections cisplatin and carboplatin in blood serum and urine of cancer patients by photometry, fluorometry, liquid chromatography using a Schiff-base as derivatizing reagent.
    Journal of pharmaceutical and biomedical analysis, 2024, Jan-20, Volume: 238

    Topics: Carboplatin; Chromatography, High Pressure Liquid; Cisplatin; Fluorometry; Humans; Indicators and Reagents; Ligands; Neoplasms; Platinum; Serum

2024
Molecular Networks of Platinum Drugs and Their Interaction with microRNAs in Cancer.
    Genes, 2023, Nov-13, Volume: 14, Issue:11

    Topics: Adenocarcinoma; Antineoplastic Agents; Carboplatin; Cisplatin; Humans; Immediate-Early Proteins; MicroRNAs; Oxaliplatin; Platinum; Trypsin Inhibitor, Kazal Pancreatic; Tumor Microenvironment; Tumor Suppressor Proteins

2023